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Apoptosis is a form of programmed cell death that is necessary for development and organism
homeostasis.

The early stages of apoptosis are marked by the permeabilization of the

mitochondrial outer membrane, the release of cytochrome c and Smac from mitochondria, and
the activation of the caspase family of proteases. The permeabilization of the mitochondria outer
membrane is thought to represent the commitment of a cell to an apoptotic fate, and the
subsequent release of mitochondrial proteins is an “all or none” phenomenon that is completed in
an individual cell within minutes. Although the cellular decision to commit to apoptosis is
important for organism homeostasis, there is considerable variability in the onset of apoptosis
between cells in culture, even in clonal populations. Here we developed a reporter (pmDEVD)
for caspase activation in single cells.

The pmDEVD reporter relocalizes from the plasma

membrane to the cytoplasm after caspase activation. We find that the reporter has similar kinetic
properties but better fold-increase properties than existing reporters.

Using the pmDEVD

reporter in single cells, we observe that the onset of caspase activity was tightly synchronized
between nearby cells. This synchrony was not a consequence of secreted factors and was not
correlated to the cell cycle. A similarity of apoptosis times was seen amongst sister and related
cells and was lost over successive generations. The times of apoptosis also diverged within a

generation, but this was blocked by inhibiting protein synthesis before triggering apoptosis.
These results suggest that the cell-cell variability of apoptosis times is due to the divergence of
the molecular composition of the cell, and that the decision to commit to apoptosis at the time of
drug addition has a deterministic component. We used the deterministic nature of apoptosis in
single cells to monitor the release of mitochondrial release at a rapid temporal resolution. At a
rapid time resolution, we find that the release of cytochrome c propagates throughout the cell as
a spatially coordinated wave. The permeability of the outer membrane to Smac propagates with
the same spatial pattern as cytochrome c but lagging in time. This is followed by a wave of
increased permeability of the inner membrane to protons. Only afterward do the mitochondria
fission. The spatial dependence of the permeability wave was inhibited by thapsigargin, an
inhibitor of the endoplasmic reticulum calcium pumps, but buffering cytosolic calcium had no
effect. Altogether, these results demonstrate the organized dynamics of apoptosis. First the onset
of apoptosis in a single cell has a deterministic component, and second, the trigger for apoptosis
is spatially localized, initiating at one or only a few mitochondria and then propagating across the
cell.
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Chapter1: Introduction

Apoptosis is a form of programmed cell death which eliminates harmful or
unwanted cells in multi-cellular organisms (Ellis et al., 1991). Generally, apoptosis is
important for organism development and in the maintenance of organism homeostasis.
Below is an overview of some of the early observations of cell death and apoptosis, and
some of the organelles and molecules involved in apoptosis with an emphasis on aspects
relevant to this thesis.

Early Observations of Cell Death
Early reports of cell death date back to at least 1842 with experiments on cell
death in insect metamorphosis (Clarke and Clarke, 1996). Over the next decades, studies
on cell death focused on phagocytosis (the process where one cell engulfs another
otherwise healthy cell) (Tauber, 2003), and necrosis (the death of injured cells) (Majno
and Joris, 1995). Cell death was also observed in various developing organisms, and was
eventually proposed to play a vital role (and not a detrimental role) in organism
development (Glucksmann, 1951). Experimental manipulation of cell death in organisms
was reported in the 1950‟s by Rita-Levi Montalcini and Viktor Hamburger on neuronal
cell death in the chick embryo. These experiments described cell death in response to
1

limb bud removal (Levi-Montalcini, 1987; Hamburger and Levi-Montalcini, 1949), and
they later identified the nerve growth factor (NGF) as a molecule that was preventing cell
death (Levi-Montalcini, 1987).

Morphological Characterization of Cell Death
The application of electron microscopy to biological specimens beginning in the
1940‟s enabled more detailed observations of the morphology and organelles present
within cells (Porter et al., 1945). The application of electron microscopy to necrotic cell
death showed swelling of organelles and of the cell (Kerr, 1969; Kerr, 1970). A separate
type of cell death (autophagy) was characterized by the formation of lysosomes and
vacuolar vesicles (Arstila and Trump, 1968). Later studies on cell death in developing
tissues revealed the contraction of cells, and the condensation of chromatin which was in
contrast to the morphology of necrotic cell death (Kerr et al., 1972). This developmental
cell death was initially referred to as shrinkage necrosis (Kerr, 1971), and was later
renamed apoptosis (Kerr et al., 1972).

Genetic Evidence of Apoptosis
A genetic program underlying cell death was suggested by experiments showing
that blocking protein and RNA synthesis inhibited cell death in insects and the tadpole
tail (Lockshin, 1969; Tata, 1966). The identification of specific cell death genes was
2

initiated by the use of C. elegans as a model system for cell death. In these organisms
131 of 1090 cells undergo cell death (Sulston and Horvitz, 1977; Sulston et al., 1983). A
close analysis of the lineage and fates of individual cells showed that the same cells were
reproducibly eliminated (Sulston, 1976), indicating that the deaths were not only
regulated on the organism level, but are also programmed at the level of single cells.
Apoptosis genes were identified by mutagenizing somatic cells of C. elegans, and
screening for cell death abnormal (ced) mutants (Ellis and Horvitz, 1986). Several
mutants were found to have defects in apoptosis including ced-3 and ced-4, both of which
are absolutely required for cell death (Ellis and Horvitz, 1986).
A separate genetic analysis using insects as a model systems uncovered several
proteins involved in programmed cell death.

In cells from the moth Spodoptera

frugiperda it was noted that mutations to the the baculovirus p35 gene could result in
apoptosis after viral infection which could be rescued by a homologous gene termed iap
present in another insect virus (Crook et al., 1993). Shortly afterwards, a genetic screen
identified a cluster of genes required for almost all programmed cell death in Drosophila
embryogenesis (White et al., 1994). The characterization of this locus resulted in the
identification of the apoptosis genes reaper, hid and grim (Chen et al., 1996; Grether et
al., 1995; White et al., 1994) which facilitate apoptosis. Later the physiological target of
the proteins encoded by these apoptosis inducing genes was identified (Drosophila
Inhibitor of Apoptosis Protein 1) which was shown to have homology to the apoptosis
repressing baculovirus p35 gene (Goyal et al., 2000). Subsequent analysis of these
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molecules suggested a system repressing programmed cell death, and a mechanism to
relieve the repression (reviewed in (Kornbluth and White, 2005)).
Insights into the genetics of mammalian programmed cell death resulted from the
cloning and characterization of the Bcl-2 proto-oncogene. The Bcl-2 gene was identified
at the chromosomal breakpoint t(14;18) in human B cell lymphoma (Bakhshi et al.,
1985).

Unlike most other oncogenes identified at the time, Bcl-2 did not induce

proliferation, but instead prevented cell death (Vaux et al., 1988). This was not only
demonstrated in cell culture, but also in mice over-expressing Bcl-2 along with c-myc which developed leukemia (McDonnell and Korsmeyer, 1991; Strasser et al., 1990), and
in Bcl-2 knockout mice developed excessive cell death of lymphocytes and melanocytes
(Veis et al., 1993). Importantly, the over-expression of Bcl-2 in C. elegans had had a
protective effect on cell death in C. elegans (Vaux et al., 1992).

This not only

demonstrated a cell death defect in human pathology, but also that cell death components
in vastly different species is functionally conserved (Vaux et al., 1992).

Since the

demonstration of an apoptotic genetic program, many apoptosis genes and molecules
have been characterized.

Molecular Components of Apoptosis Signaling
Below we give an overview of the molecules involved in mammalian apoptosis.
Two non-distinct apoptotic pathways have been defined based on whether the triggering
4

mechanism is internal to the cell (intrinsic apoptosis), or whether the apoptotic trigger is
external to the cell (extrinsic apoptosis) (Ow et al., 2008). Some intrinsic triggers include
DNA damage, endoplasmic reticulum (ER) stress, or microtubule stress. External stimuli
are often ligands which bind to receptors on the surface of the cells, and initiate signaling
that culminates in the death of the cell (Fulda and Debatin, 2006). Example ligands
include tumor necrosis factor α (TNFα) (Carswell et al., 1975), the TNF α related
apoptosis inducing ligand (TRAIL) (Wiley et al., 1995), and Fas Ligand (Suda et al.,
1993). Nonetheless, it is important to consider the overlap between molecules stimulated
by different triggers, and that these pathways may not actually be distinct.
Below is a description of some of the molecules and processes which occur in
response to apoptotic stimuli. These include the Bcl-2 family, mitochondrial associated
proteins (including cytochrome c and Smac), and the caspase family of proteases.

Mitochondria Overview
Mitochondria play a central role in the oxidative phosphorylation cycle and thus
in the generation of cellular ATP (Slater, 1977).

Electron microscopy studies of

mitochondria revealed the substructure of mitochondria which includes the outer
mitochondrial membrane (OMM), the intermembrane space (IM), the inner
mitochondrial membrane (IMM), and the mitochondrial matrix (Palade, 1953). The IMM
is organized in a manner that creates invaginations into the matrix called cristae spaces
5

(Palade, 1953; Frey and Mannella, 2000). Several membrane bound complexes exist on
the IMM which transport protons and other ions in or out of the mitochondrial matrix
(Schultz and Chan, 2001). The transport of protons creates a membrane potential (∆Ψ)
across the IMM which is required for the synthesis of ATP. The presence of a potential
across the IMM can be observed by the accumulation of lipophilic cations (such as
TMRE and TMRM), which preferentially accumulate actively respiring mitochondria
(Ehrenberg et al., 1988).
Mitochondria are highly dynamic organelles which fission and fuse with other
mitochondria (Bereiter-Hahn and Voth, 1994). The fission and fusion of mitochondria
are regulated by several proteins such as dynamin related protein 1 (Drp1), Fis1, Bax, and
many other proteins (Hoppins et al., 2007). Several human disorders are associated with
mutations in fission and fusion genes including Charcot-Marie-Tooth-subtype 2A and
dominant optic atrophy (Alexander et al., 2000; Pedrola et al., 2005). Notably some of
these fission/fusion proteins are also involved in apoptosis (Suen et al., 2008).

Mitochondrial Role in Apoptosis
The mitochondrial localization of Bcl-2 in mammals and ced-4 in C. elegans
suggested that the mitochondria play significant roles in apoptosis (Hockenbery et al.,
1990).

Since then various proteins associated with the mitochondria have been

discovered to be involved in apoptosis. Some of these molecules include the Bcl-2
6

family of molecules, cytochrome c, Smac/DIABLO, and Omi, among many others (Ow
et al., 2008). Furthermore, modifications to the mitochondria structure occur during
apoptosis including mitochondrial fission and fragmentation (ROUILLER, 1957; Zhuang
et al., 1998), loss of mitochondrial intermembrane space potential (Goldstein et al.,
2000), and changes in the geometry of the mitochondria cristae spaces (Sun et al., 2007).
Below we discuss some of the mitochondrial associated molecules relevant to this thesis
and their involvement in apoptosis.

Bcl-2 Family
The Bcl-2 family of proteins play critical roles in the release of mitochondrial
proteins during apoptosis (Kluck et al., 1997; Yang et al., 1997). The expression and
concentration of specific Bcl-2 molecules have been proposed to determine the sensitivity
of cells to some apoptotic signals and some chemotherapies (Danial and Korsmeyer,
2004; Deng et al., 2007). Bcl-2 itself was identified at the chromosomal breakpoint of
t(14;18) in human B cell lymphoma (Bakhshi et al., 1985; Cleary and Sklar, 1985).
Further Bcl-2 related molecules were identified through protein-protein interactions or
based on sequence homology. At least 19 Bcl-2 molecules have been identified to play a
role in apoptosis (Wang and Youle, 2009). These molecules can be classified based on
the presence of four Bcl-2 Homology (BH) domains, and their presumptive role in
apoptosis (Table 1, Figure 1) (Danial and Korsmeyer, 2004).
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TABLE 1: Bcl-2 molecules
BH3 Only

Anti-Apoptotic

Pro-Apoptotic

Bad

Bcl-2

Bax

Bim

Bcl-XL

Bak

Bid

Mcl1

Bok

Noxa

A1

Puma

Bcl-W

Bik

Bcl-Rambo

Hrk

Bcl-L10

Bmf

Bcl-10

8

Figure 1: Proposed roles of Bcl-2 and mitochondrial proteins during apoptosis.
Anti-apoptotic (blue) and BH3-only (orange) molecules control the activity of the
pro-apoptotic (yellow) Bcl-2 molecules. Oligomerization of pro-apoptotic molecules
results in the release of mitochondrial proteins such as cytochrome c and Smac. The
diagram does not include all known Bcl-2 molecules.

9

Bcl-2 molecules have a variable number of the four distinct BH3 domains. The
number of domains roughly correlates with the apoptotic function of the molecule
(Danial and Korsmeyer, 2004). Pro-apoptotic molecules (such as Bax and Bak) possess
BH domains 1-3, and are directly involved in the release of apoptotic mitochondrial
proteins (Chittenden et al., 1995; Zha et al., 1996a). The BH3-only molecules enable the
apoptotic function of Bax and Bak either by direct or indirect stimulation (Boyd et al.,
1995; Lomonosova and Chinnadurai, 2008). The third category of Bcl-2 molecules
possesses BH1-4 domains, and inhibit the pro-apoptotic or the BH3-only molecules
(Muchmore et al., 1996; Danial and Korsmeyer, 2004). The subcategories of the Bcl-2
family are discussed in more detail below. Notably, there is significant controversy on
the interactions of the Bcl-2 molecules and how they permeabilize the mitochondrial
outer membrane (Antignani and Youle, 2006; Chipuk et al., 2010).

Bax/Bak
During apoptosis Bax and Bak undergo conformational changes and oligomerize
at discrete sites on the mitochondria (Nechushtan et al., 2001). The oligomerization of
Bax and Bak is proposed to result in the permeablization of the mitochondria and the
release of cytochrome c, Smac/DIABLO and other molecules involved in the execution
of apoptosis. A double knockout of Bax and Bak blocks the release and inhibits caspase3 processing and activity in response to intrinsic stimuli (Wei et al., 2001). While
10

extrinsic stimuli such as TNFα is still able to induce caspase activation in Bax/Bak
double knockout cell lines, it is not able to induce cytochrome c release (Wei et al.,
2001).
Bax is a monomeric protein that is localized in the cytoplasm and loosely
associated with mitochondria (Hsu et al., 1997). It is comprised of 9 α-helices which
form a hydrophobic pocket that is occupied by its C-terminal helix in its inactive state
(Suzuki et al., 2000). During apoptosis Bax translocates to the mitochondria, and inserts
into the outer membrane (Nechushtan et al., 2001; Gross et al., 1998), with liposomal
assays suggesting that α-helices 5, 6, and 9 insert into the outer mitochondrial membrane
(Annis et al., 2005).

Bax then proceeds to oligomerize at discrete sites on the

mitochondria rather than uniformly throughout the mitochondria (Nechushtan et al.,
2001; Lovell et al., 2008). Although large Bax oligomers form on the mitochondria,
experiments on isolated mitochondria or on liposomes suggest that only a few molecules
are minimally required for permeabilization (Saito et al., 2000; Martinez-Caballero et al.,
2009). Furthermore, live cell imaging of Bax fused to the green fluorescent protein
(GFP) indicates that the majority of Bax accumulation at the mitochondria occurs after
the permeabilization of the mitochondrial outer membrane (Dussmann et al., 2010).
Unlike Bax, Bak is constitutively associated with the mitochondrial membrane
and the endoplasmic reticulum (Zong et al., 2003; Wei et al., 2000). Prior to apoptosis
Bak can associate with anti-apoptotic proteins such as Mcl-1 and Bcl-xL (Willis et al.,
2005), and also with VDAC (Cheng et al., 2003). However, co-immunoprecipitation
11

experiments suggest that Bax and Bak are not all be constitutively associated with antiapoptotic Bcl-2 proteins, and may exist as monomers (Hsu and Youle, 1997; Cheng et al.,
2001). The precise mechanism of how Bax/Bak is activated and regulated by other Bcl-2
members is unclear, though several models have been proposed to explain their
regulation (Chipuk and Green, 2008); these are discussed in more detail in a later section.
Nonetheless, during apoptosis Bak redistributes on the mitochondria and electron
microscopy images indicate that Bak is found at discrete sites after apoptotic stimuli
(Nechushtan et al., 2001). Bax and Bak double knockout lines also display altered
mitochondrial morphology and mitochondrial fusion (Karbowski et al., 2006) which may
suggest a link between mitochondrial morphology and apoptosis, or non-apoptotic
functions of Bax and Bak.
Various mechanisms have been proposed for how Bax and Bak mediate the
release of cytochrome c. These include the formation of a proteolipid pore or channel
(Basanez et al., 2001; Martinez-Caballero et al., 2009), and the modification of an
existing channel (Kroemer et al., 2007). Evidence supporting the role of a modified pore
is based on the ability of Bax to accelerate the opening of a voltage dependant ion
channel (VDAC) in liposomes (Shimizu et al., 1999). VDAC along with the adeninenucleotide translocase (ANT) was proposed to form the permeability transition pore
(PTP) which induces the swelling of the matrix, the rupturing of the mitochondria, and
the release of cytochrome c. However, knockouts of VDAC or ANT do not recapitulate
the phenotype of the Bax/Bak double knockout (Baines et al., 2007; Kokoszka et al.,
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2004).

Nonetheless it is possible that another modified channel is necessary for

cytochrome c release but has not been identified.
Some evidence support the existence of Bax/Bak protein pores.

First Bcl-2

proteins are structurally similar to bacteria pore toxins suggesting Bax and Bak may
permeabilize the OM in a similar way (Muchmore et al., 1996). Furthermore, Bax can
permeabilize synthetic liposomes which lack the additional proteins present in the
mitochondrial membrane (Saito et al., 2000). However, while the existence of a channel
or a pore has been proposed with Bax or Bak as the major component, key structural and
biochemical evidence of a pore is lacking (Antignani and Youle, 2006; Chipuk and
Green, 2008).

Bcl-2 Inhibitors
Several Bcl-2 molecules inhibit the association of Bax and Bak into oligomers.
These include Bcl-2, Bcl-xL, Bcl-W, MCL-1 and A1. Individual Bcl-2 anti-apoptotic
molecules are proposed to have specific interactions with Bax and Bak (Willis et al.,
2007) or with the BH3 only proteins (Chen et al., 2005; Letai et al., 2002; Kim et al.,
2006). However there is some disagreement on the interactions between anti-apoptotic
and pro-apoptotic proteins (Chipuk and Green, 2008).

For example one

immunoprecipitation study found that Bcl-xL is associated with Bak prior to apoptosis
(Willis et al., 2005), whereas another study did not detect an interaction (Cheng et al.,
13

2001). Several possibilities explaining this difference could include an experimental
difference in cell types, expression levels or in purification processes. More generally,
the precise mechanism of inhibition, and the nature of these interactions remain unclear
and are discussed in detail below (see Models of Bax/Bak Activation). Several drugs
have been designed to inhibit Bcl-2 anti-apoptotic proteins to enable the progression of
apoptosis in tumors or tumor cells (Oltersdorf et al., 2005; Nguyen et al., 2007).

Bcl-2 Sensitizers and BH3-Only Proteins
The activation of Bax and Bak depends in part on the state of a subset of the Bcl-2
family called the BH3-only proteins (Wang et al., 1996). These include Bad, Bim, Bid
and Noxa/Puma among other proteins (Giam et al., 2008). The activity of the BH3-only
proteins can be modified post-translationally. These can include the inactivation of Bad
and the activation Bim by phosphorylation events (Harada et al., 1999; Lei and Davis,
2003). Additionally, the pro-apoptotic function of Bid results from the cleavage of the
amino terminal resulting in truncated Bid (tBid) (Zha et al., 1996b; Li et al., 1998;
Hubner et al., 2008).

14

Models of Bax and Bak Activation
Two often cited models have been proposed to explain the mechanism by which
the Bcl-2 pro- and anti-apoptotic molecules proteins activate the Bax and Bak effector
molecules. One model proposes that Bax and Bak can be directly activated by a subset of
BH3 only molecules which interact with and structurally modify the effector proteins,
and that the remaining BH3 molecules can alter the apoptotic sensitivity of mitochondria
by inhibiting anti-apoptosis Bcl-2 proteins, but cannot themselves directly activate Bax or
Bak (Kim et al., 2006). For example, it is thought that tBid (an activated and cleaved
form of Bid) enables the association of Bax with mitochondria membrane based on in
vitro liposomal experiments in the absence of other proteins (Lovell et al., 2008). More
generally, of the BH3 peptides from BH3 only proteins, only Bid, Bim and Puma
peptides were able to induce Bax mediated liposomal or mitochondrial permeabilization
without the addition of other proteins (Letai et al., 2002). One of the objections to this
model is the poorly detected interaction between Bax/Bak and the direct activator
proteins (Willis et al., 2007) – which could indicate a transient interaction, but may also
indicate that a direct activation of Bax and Bak is not a physiologically relevant signal.
Alternatively, it is possible that the BH3 only proteins interact with the Bcl-2
inhibitors, there by disengaging Bax or Bak from the anti-apoptotic inhibitor . In these
models, Bcl-2 inhibitors would constantly keep Bax or Bak from being activated until
disengaged by the BH3 only molecules (Adams and Cory, 2007). In support of this
model is that while BH3 only peptides can engage Bax or Bak (Letai et al., 2002), there is
15

little or no interaction between these BH3 proteins and Bax/Bak in cells (Willis et al.,
2007). Moreover, there is detectable interaction between over expressed anti-apoptotic
proteins with Bak (Willis et al., 2005). One of the objections to this model is that several
immunoprecipitation experiments indicate that Bax and Bak exist as monomers in vivo
(Hsu and Youle, 1997; Cheng et al., 2001). These unattached and yet inactive Bax/Bak
molecules are in apparent contradiction to this model – though one possibility is that
there are other forms of Bax/Bak sequestering and inhibition that is not fully understood.
Finally, another possibility is that both of these models are insufficient to explain the Bcl2 family interactions, and a newer model is needed.

Cytochrome c
Cytochrome c was initially discovered for its role in the electron transport chain
and in the production of ATP (Slater, 1977). It is synthesized in the cytosol, and is
imported into the mitochondria where it acquires a heme group. The heme group consists
of an iron molecule which can covert between Fe2+ and Fe3+, thus enabling cytochrome
c to serve as an electron donor and acceptor. In the context of the electron transport
chain, cytochrome c transports electrons between Complex III and Complex IV (Schultz
and Chan, 2001). Cytochrome c is predominantly localized to the intermembrane space
of mitochondria and is thought that 85% of mitochondrial cytochrome c resides in the
cristae spaces of the mitochondria (Bernardi and Azzone, 1981) where it associates with
cardiolipin (Ott et al., 2007).
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Early cell-free experiments indicated the depletion of mitochondria from Xenopus
extracts reduced caspase activity suggesting that a mitochondrial protein is required for
the activation of caspase-3 (Newmeyer et al., 1994).

Using biochemical and

centrifugation techniques caspase activation was shown to require cytochrome c, ATP,
and another factor called the apoptosis protease activating factor-1 (Apaf-1) (Liu et al.,
1996). Cell lines derived from knockout cytochrome c mice show reduced caspase-3
activation, however are able to undergo apoptosis in response to some stimuli (Li et al.,
2000). Knocking in a mutagenized cytochrome c (K72A) that functions in the electron
transport chain, but does not bind to Apaf-1 results in mice in which the majority died
prenatally, but with a few that were able to survive for several weeks (Hao et al., 2005).
Furthermore, while K72A MEFs are resistant to apoptosis induced by UV irradiation,
K27A thymocytes display a similar apoptosis response as the wild-type cytochrome c
thymocytes (Hao et al., 2005). Thus, the survival of some of the K27A mice, along with
the similar apoptosis response of K72A thymocytes suggests that there may be
cytochrome c independent mechanisms required for apoptosis.
Once in the cytosol, cytochrome c can interact with individual molecules of Apaf1 (Zou et al., 1997).

These molecules then oligomerize into a complex called the

apoptosome which is able to induce caspase activity (Li et al., 1997; Zou et al., 1999).
Furthermore, once cytochrome c relocalizes from the mitochondria to the cytosol, it can
also interact with the inositol triphosphate receptor (IP3R) which is embedded in the
endoplasmic reticulum (ER) and controls calcium release (Boehning et al., 2003). The
cytochrome c- IP3R interaction is proposed to enable the release of calcium from the ER,
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which in turn can induce the release of cytochrome c from other mitochondria, thus
amplifying the initial release cytochrome c (Boehning et al., 2003; Boehning et al., 2005).
Cytochrome c-GFP fusions have been found to localize to mitochondria prior to
apoptosis, however this takes considerable time (>48 hours) to properly localize to
mitochondria (personal communication D. Boehning). The release of cytochrome c GFP
from mitochondria is complete within minutes, and is proposed to occur in a spatially
invariant manner through the cell (Goldstein et al., 2000; Munoz-Pinedo et al., 2006).
Coincident with the release of cytochrome c, mitochondrial intermembrane potential
(∆Ψ) is also lost, though inhibitors of caspase activation can delay ∆Ψ loss (MunozPinedo et al., 2006). Nonetheless, the acquisition frequency of the images in these
studies is similar to the phenomenon that is being imaged, thus potentially masking finer
dynamic behavior.

Smac/DIABLO
During apoptosis, Smac/DIABLO (second mitochondria-derived activator of
caspases / direct IAP-binding protein with low pI) is also released from the mitochondria
(Du et al., 2000; Verhagen et al., 2000). Smac is synthesized in the cytosol and when
imported into the mitochondria, the 55 N-terminal amino acids are cleaved resulting in
the 4 amino acids at the N-terminal AVPI (Burri et al., 2005). The processing of Smac
and the post-translocation AVPI amino terminal plays a role in promotion of caspase
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activity (Wu et al., 2000). The processed form of Smac resides in the intermembrane
space of mitochondria, with crystallography and biochemical data suggesting that it exists
as a homodimer (Chai 2000). Once released into the cytosol, Smac can interact with
Inhibitor of Apoptosis (IAP) proteins which themselves can directly inhibit or antagonize
caspase activity (Verhagen et al., 2000; Du et al., 2000). Smac is proposed to inhibit IAP
activity by substrate competition, direct IAP binding and inhibition or by inducing IAP
degradation (Lacasse et al., 2008). The precise mode of inhibition is somewhat unclear
and depends on the specific IAP; this is discussed in more detail in a later section.
Splice variants of Smac include Smac-beta, and Smac3. Smac-beta does not
localize to the mitochondria, and does not bind to IAPs, however, its overexpression can
predispose cells to certain apoptosis stimuli (Roberts et al., 2001). By comparison,
Smac3 does localize to mitochondria, is released during apoptosis, and can trigger
degradation of XIAP (Fu et al., 2003). Smac knockout mice are viable, and still undergo
apoptosis in response to a variety of stimuli (Okada et al., 2002).

One possibility

explaining the viability of Smac knockout mice is the redundancy of Smac in apoptosis,
or alternatively, a splice variant may compensate for the Smac knockout.
Smac release is presumed to occur at the same time as cytochrome c release
(Munoz-Pinedo et al., 2006), and it has been suggested that they are released by the same
mechanism. However this order may depend on the apoptosis inducing drug and the
genetic background of the cell. For example in mouse embryonic fibroblasts (MEFs)
from Bid, Bad or Bak single knockout mice, in response to TRAIL treatment, Smac
19

release is inhibited while cytochrome c release occurs (Kandasamy et al., 2003). This
suggests that different mitochondrial modifications may be needed for Smac or
cytochrome c release.

Even more interesting is that Smac release is inhibited in

cytochrome c KO mice (Hansen et al., 2006). This may indicate a feedback loop in
which cytosolic cytochrome c is required for Smac release in single cells.

Apaf-1
Apaf-1 forms a critical part of the apoptosome which activates the caspase-9, and
in turn caspase-3 (Li et al., 1997; Zou et al., 1997). While the majority of Apaf-1
knockout mice are embryonic lethal, (depending on the genetic background of the mice),
a small percentage can survive to adulthood (Yoshida et al., 1998; Honarpour et al.,
2000). MEFs isolated from Apaf-1 knockout mice undergo apoptosis, and are more
resistant to some apoptotic triggers than the cytochrome c K72A knockin mice suggesting
that there may be cytochrome c independent but Apaf-1 dependant mechanisms to induce
apoptosis (Hao et al., 2005).
Apaf-1 consists of a caspase recruitment domain (CARD) and two WD40
domains (Hu et al., 1998; Li et al., 1997). Prior to cytochrome c release from the
mitochondria, Apaf-1 exists as a cytosolic monomer with its CARD domain bound to its
WD40 domain (Acehan et al., 2002; Li et al., 1997; Zou et al., 1999). When released into
the cytoplasm, cytochrome c binds to the Apaf-1 WD40 domain exposing the CARD
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domain. The presence of ATP enables the oligomerization of Apaf-1 into a wheel like
structure consisting of approximately 7 Apaf-1 proteins (Acehan et al., 2002; Li et al.,
1997), with the Apaf-1 CARD domains located in the center. The CARD domains bind
to caspase-9 thus forming the macromolecular complex called the apoptosome (Zou et
al., 1999). It is proposed that the proximity of caspase-9 at the center of the apoptosome
enables the activation of caspase-9 (Li et al., 1997; Rodriguez and Lazebnik, 1999;
Stennicke et al., 1999)

Other Mitochondrial Modifications during Apoptosis
During apoptosis, the structure of the mitochondria undergoes several changes.
Mitochondria cristae junctions become wider, and at a later time the cristae structure
changes from being long and tubular, to spherical and round (Sun et al., 2007). Opa1 – a
protein that is localized in a macromolecular complex at the cristae junction – is cleaved
during apoptosis enabling the widening of the cristae (Pellegrini and Scorrano, 2007).
This is proposed to allow the passage of cytochrome c out of the cristae space (Scorrano
et al., 2002). However, the temporal ordering of Opa1 cleavage and cytochrome c
relocalization within the mitochondria has yet to be directly measured.
Mitochondria also become fragmented during apoptosis, and in some instances
swell. This was initially thought to be a mechanism of release of cytochrome c, but direct
imaging shows that cytochrome c release occurs before significant swelling (Goldstein et
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al., 2005). Mitochondria also lose their membrane potential during apoptosis at a similar
time as cytochrome c release (Munoz-Pinedo et al., 2006). However, the addition of
caspase inhibitors delays loss of membrane potential, while still enabling cytochrome c
release (Goldstein et al., 2000).

Caspases
Caspases are a family of proteases that are involved in apoptosis, inflammation,
differentiation, and neuronal pruning, among other functions (Kumar, 2007).

In

mammalian cells, at least fourteen caspases have been identified and are referred to as
caspase-1 through caspase-14 according to defined nomenclature (Alnemri et al., 1996).
The caspases are characterized by a cysteine nucleophile in their active site, and the
requirement for cleavage of substrates after aspartic acids (aspase) (Thornberry et al.,
1992). Caspases are translated as inactive precursors called zymogens or procaspases
which zymogens contain an inhibitory N-terminal prodomain of variable size, and a large
and small subunit (17-20 kDa and 10-12 kDa respectively) (Yan and Shi, 2005). The
activation of caspases represents a critical step in the progression of apoptosis resulting in
the cleavage of transcription factors, translation factors, cellular structures, among other
vital cellular components (Dix et al., 2008; Timmer and Salvesen, 2007).
Caspase-1 was the first identified mammalian caspase as the protease responsible
for the cleavage and activation of the precursor of IL-1β, and was accordingly named IL22

1β Converting Enzyme (Cerretti et al., 1992).

Shortly afterwards, the molecular

characterization of the protein encoded by the C. elegans ced-3 gene resulted in
identification of an enzyme with significant homology to the active region of caspase-1
(Yuan et al., 1993). Since these initial discoveries, families of caspases have been
discovered in various organisms identified and were found to play a role in apoptosis
(and other processes) (Vaux and Korsmeyer, 1999).
Caspases-2,-3,-6,-7,-8,-9 and -10 play roles in response to various apoptotic
stimuli. These are classified as initiator caspases or as executioner caspases based on the
length of their prodomains, and on their presumed function in apoptosis (Table 1) (Yan
and Shi, 2005). Initiator caspases are activated early in apoptosis and have prodomains
that are longer than 90 amino acids. These pro-domains enable the association with other
molecules required for caspase activation (Yan and Shi, 2005). In contrast executioner
caspases have significantly shorter prodomains (20-30 amino acids), are active late in
apoptosis, and when activated, cleave a large number of cellular substrates (Dix et al.,
2008; Timmer and Salvesen, 2007). The early/late involvement is largely based on
genetic evidence (Kumar, 2007) and immunodepletion of in vitro cultures (Slee et al.,
1999). Thus, these experiments do not preclude the existence of overlapping activities, or
of a synergistic relationship between initiator and executioner caspases.
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Table 2: Classification of Apoptotic Caspases
Initiator

Executioner

Caspase-9

Caspase-3

Caspase-8

Caspase-6

Caspase-10

Caspase-7

Caspase-2

Caspase-9
Once released from the mitochondria, cytochrome c and Apaf-1 associates with
caspase-9 to form the apoptosome which in turn processes and activates caspase-3 (Li et
al., 1997).

After translation, caspase-9 is localized in the cytosol and exists as a

monomer (Stennicke et al., 1999; Renatus et al., 2001). It consists of an N-terminal prodomain with a caspase recruitment domain (CARD) which is responsible for the
association of caspase-9 with Apaf-1 (Li et al., 1997). Caspase-9 knockout mice reveal
excessive brain tissue resulting from decreased apoptosis, and are embryonic or perinatal
lethal depending on the genetic background (Hakem et al., 1998; Kuida et al., 1998).
While caspase-9 can be cleaved, the activation of caspase-9 does not require the
removal of its N-terminal prodomain (Stennicke et al., 1999). Two hypothesis exist for
the activation of caspse-9: the induced proximity model and the allosteric model
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(Boatright and Salvesen, 2003; Shi, 2004). The allosteric model proposes that caspase-9
monomers are activated directly (Rodriguez and Lazebnik, 1999), while the induced
proximity model proposed that the association of caspase-9 monomers in the apoptosome
brings caspase-9 close together which enables the multimerization of caspase-9 and thus
its activation (Boatright et al., 2003).

Caspase-3 and Caspase-7
In mammalian cells, caspase-3 is presumed to be the major executioner caspase
that cleaves the majority of cellular substrates. Caspase-3 can be processed and activated
by initiator caspases such as caspase-8, and -9, or by executioner caspases such as
caspase-7 and caspase-3 itself (Pop and Salvesen, 2009). Several substrates of caspase-3
include poly(ADP-ribose) polymerase (PARP), actin, and many other vital cellular
proteins (Dix et al., 2008; Timmer and Salvesen, 2007). Caspase-7 is highly similar to
caspase-3 based on sequence homology, and based on the cleavage of preferred
substrates (Fuentes-Prior and Salvesen, 2004; Thornberry et al., 1997). Furthermore,
their inactive and active structures show similar features (Chai et al., 2001; Mittl et al.,
1997; Riedl et al., 2001; Rotonda et al., 1996).
Shortly after translation, caspase-3 and caspase-7 zymogens form inactive dimers
in the cytosol (Yan and Shi, 2005). In this pre-apoptotic form, the activity of executioner
caspases is inhibited by the presence of the prodomain and by spacers between the large
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and small subunits (Boatright and Salvesen, 2003). Executioner caspases are processed
by the initiator caspases, resulting in the removal of the pro-domain and cleavage of the
small and large subunits. Structural studies indicate that the cleavage of the linker
between the small and large subunit enables a structural rearrangement and formation of
the catalytic site (Yan and Shi, 2005). The result is an active executioner caspase is a
tetramer consisting of two large and two small subunits (Chai et al., 2001; Mittl et al.,
1997; Riedl et al., 2001; Rotonda et al., 1996).
Caspase-3 knockout mice were initially thought to be embryonic lethal, with
significant cell survival in the central nervous system (Kuida et al., 1996). However, in
different genetic backgrounds, caspase-3 knockout mice survive to birth, with
cardiovascular defects (Lakhani et al., 2006). Similar results are seen of caspase-7
(Lakhani et al., 2006). These single knockout experiments suggest that caspase-3 and
caspase-7 are not absolutely necessary for apoptosis in all tissues, and that they may have
overlapping functionality. While caspase-3 and -7 double knockout mice can survive to
birth, they die shortly afterwards, and display significant heart development problems
(Lakhani et al., 2006).

Furthermore, the double knockout mice show delayed

mitochondrial permeabilization suggesting that there may be a caspase feedback loop to
amplify cytochrome c release (Lakhani et al., 2006).
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Caspase-8 and Caspase-10
Caspase-8 and caspase-10 are important components of apoptosis induced by
extracellular ligands such as TRAIL, sFasL or TNFα (Muzio et al., 1996; Boldin et al.,
1996). Caspase-8 knockout mice are embryonic lethal with defects in cardiac and T-cell
development (Varfolomeev et al., 1998). The defects in the KO mice result in a lack of
apoptosis induced by death receptors, however apoptosis still occurs in response to
intrinsic stimuli (Varfolomeev et al., 1998).

Caspase-8 consists of an N-terminal

prodomain with 2 repeats of the death effector domain (DED).

The DED enables

association with the death domains (DD) in the adaptor proteins FADD and TRADD
(Boldin et al., 1996; Carrington et al., 2006). In response to sFasL, caspase-8 associates
with a macromolecular complex called the death induced signaling complex (DISC) at
the plasma membrane resulting in caspase-8 activation (Lee et al., 2006). In contrast,
when cells are treated with TNFα, caspase-8 does not associate with the DISC at the
plasma membrane, but instead forms an oligomer with FADD in the cytosol where
caspase-8 is activated (Micheau and Tschopp, 2003).

The mechanism of caspase-8

activation remains unclear and is proposed to auto-activate upon close proximity (Lee et
al., 2006). Once activated casapase-8 can cleave and activate Bid which enables the
association of Bax with mitochondria and release of cytochrome c from the mitochondria
(Li et al., 1998). Alternatively, caspase-8 can directly process and activate caspase-3
(Stennicke et al., 1998).
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Caspase-2
Caspase-2 is an apical caspase that is response the activation of cell death in
response to DNA damage, TRAIL and heat shock stimulus (Tinel and Tschopp, 2004; Tu
et al., 2006). Like other apical caspases, it contains a long pro-domain, which has a
CARD protein-protein interaction domain (Baliga et al., 2004).

The activation of

caspase-2 is thought to occur in a similar manner to caspase-9. Prior to apoptosis,
caspase-2 is a monomer, and after an apoptotic stimulus, it binds to the protein RAIDD in
a multimeric scaffolding platform called the PIDDosome (Tinel and Tschopp, 2004).
Here multiple caspase-2 molecules are brought into close proximity which is thought to
activate it.

Cleavage Preferences of Caspases
Several studies have been performed to identify the optimal substrates that will be
processed by caspases for the purposes of creating specific reporters of caspase activity.
The initial studies identifying substrate preference were based on fluorogenic substrates
with four amino acids that bind to the active sites of caspases (Thornberry et al., 1997).
Caspase-9 prefers the four amino acid sequence „LEHD‟, and caspase-8 prefers the
sequence „IETD‟. Caspase-3 and -7 have similar substrate preferences for the sequence
„DEVD‟, however they are also able to efficiently cleave both LEHD and IETD
(Thornberry et al., 1997). Extending the substrate size beyond four amino acids results in
greater substrate specificity, however there is still considerable overlap (Stennicke et al.,
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2000). This redundancy is likely a beneficial feature in the event that a particular caspase
is mutagenized and inactivated, however it makes the design of a reporter for specific
caspase activity difficult (McStay et al., 2008).

Inhibitor of Apoptosis Proteins
In contrast to the molecules involved in the activation of caspases, the activation
of caspases can be inhibited by a class of proteins called the inhibitor of apoptosis family
(IAP). The IAP family consists of eight distinct molecules which contain several BIR
(baculovirus IAP repeat) domains, and in some instances a CARD domain, and a RING
domain (Salvesen and Duckett, 2002).

The proposed mechanisms of IAP-caspase

inhibition is specific to an IAP member, and can occur via direct inhibition of active
caspases, inhibition of caspase processing, or in promoting the degradation of caspases
(LaCasse et al., 2008). These are discussed in detail below.
In Drosophila, the IAP homolog Drosophila IAP-1 (Diap1) functions as a
ubiquitin ligase which marks Dronc (caspase-9 homolog) for degradation (Wilson et al.,
2002). In mammalian cells, the clearest demonstration of IAP-caspase inhibition is the
interaction between caspases-3, 7, and 9, and XIAP (Deveraux et al., 1998). XIAP can
bind to caspase-3, 7 and 9, and is proposed to interfere with the active sites of the
caspases, or with dimerization (Scott et al., 2005; Shiozaki et al., 2003). Some evidence
suggests that cIAP1 and cIAP2 can also inhibit caspase activity, though this may occur
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through a different mechanism than XIAP. Specifically, studies in yeast indicate that
activation of exogenous mammalian caspase-3 can be inhibited by the expression of
cIAP1 and cIAP2 (Wright et al., 2000). Initially, it was thought that cIAP1 and cIAP2
are able to bind and directly inhibit caspase activation (Roy et al., 1997), but later studies
suggest that while cIAP1/2 can bind to caspases-3/7, the direct inhibition may be an
experimental artifact (Eckelman et al., 2006). Alternatively, cIAP1 and 2 may antagonize
caspase activation by ubiquitination (LaCasse et al., 2008).
The relief of XIAP inhibition during apoptosis can be in part attributed to the
release of Smac from mitochondria (Du et al., 2000; Verhagen et al., 2000). Initially, it
was thought that Smac antagonizes the XIAP inactivation of caspase-9 by competition
(Srinivasula et al., 2001). However Smac is unable to relieve the inhibition between
BIR3 of XIAP and caspase-9, but is able to relieve the inhibition of caspase-9 by XIAP
lacking BIR1, suggesting that simple substrate competition may not be the mechanism of
Smac-XIAP inactivation (Huang et al., 2003).
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Genetically Encoded Fluorescent Proteins
We extensively use light and fluorescence microscopy to observe the dynamics of
various apoptotic events in single cells. The characterization and cloning of the green
fluorescent protein (GFP) was a technological advance in the fluorescent tagging of
proteins (Prasher et al., 1992) (Shimomura, 2009). GFP is a fluorescent molecule found
in the jellyfish Aequeora Victoria (Shimomura, 2009).

The application of GFP to

imaging in organisms first enabled the observation of single cells in C. elegans which had
specific active promoters (Chalfie et al., 1994), and more recently has been applied to
simultaneously image many distinct cells in fixed tissues (Livet et al., 2007).

GFP has a specific excitation and emission spectra. The wild type GFP required
UV excitation which is not ideal for the long term imaging of cells (Heim et al., 1994).
Significant work was performed to mutagenize GFP, to improve its spectral properties as
well as its brightness and photostability (Heim et al., 1995; Heim et al., 1994). Further
mutagenesis altered the emission spectra of GFP resulting in the development of the cyan
fluorescent protein (CFP), the yellow fluorescent protein (YFP) and other fluorescent
proteins with similar fluorescent properties such as mCerulean, mCitrine (Griesbeck et
al., 2001; Rizzo et al., 2004). The discovery of DsRed enabled visualization of proteins
at longer wavelengths (Matz et al., 1999; Baird et al., 2000). The mutagenesis of DsRed
improved its spectral properties, but also enabled the characterization of a monomeric red
fluorescent protein (mRFP) (Campbell et al., 2002), and later the generation of several
fluorescent

proteins

with

varied

emission
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wavelengths

(mCherry,

mOrange,

mStrawberry, mPlum) (Shaner et al., 2004). A diverse set of proteins can be used in
combination with the appropriate set of spectral filters to separately image different
molecules.

For example, it is easily possible to image mCerulean, mCitrine, and

mCherry (Shaner et al., 2005).

Table 3: Genetically Encoded Fluorescent Proteins
Fluorophore

Excitation

Emissions

Cerulean

433

475

EGFP

488

507

mCitrine

516

529

mCherry

587

610
(Shaner et al., 2005)

Caspase and Protease Reporters
Various reporters of caspase reporters exist which involve a change of
fluorescence or fluorophore localization upon caspase activation (Figure 2). Existing
reporters for live caspase activity include a reporter which undergoes a change in Forster
Resonance Energy Transfer (FRET) after caspase activation (Nguyen and Daugherty,
2005; Xu et al., 1998), and a separate reporter that transitions from being in both the
cytoplasm and the nucleus to being solely in the nucleus after caspase activation
(pCaspase-3 Sensor, Clontech).

32

Figure 2: Image of existing caspase reporters. (A) Design of the FRET caspase
reporter. (B) Prior to caspase activation, CFP and YFP molecules are proximal
resulting in an energy transfer between CFP and YFP. After caspase activation,
CFP and YFP are separated resulting in significantly less energy transfer and less
YFP emission. (C) Design of the pCaspase-3 sensor. This consists of a fluorophore
and a nuclear localization signal (NLS) which are separated from a nuclear export
signal (NES) by a DEVD amino acid linker. (B) The pCaspase-3 sensor initially
exists in both the cytoplasm and the nucleus. After caspase activation, the nuclear
export signal is removed and the fluorophore relocalizes to the nucleus.
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The FRET reporter consists of two fluorophores which are held together by a
linker region which contains the amino acids DEVD (Figure 2A,B). The close proximity
of the two fluorophores enables a non-photon mediated energy transfer (Andrews, 1989)
from an excited donor fluorophore to the acceptor fluorophore, and thus emission from
the acceptor fluorophore at its characteristic emission signature. Upon caspase activity
the DEVD linker is cleaved resulting in the separation of the fluorophores, loss of the
energy transfer, and therefore the loss of emission from the acceptor fluorophore.
Although monitoring the activation of caspase-3/7 can be achieved with FRET reporters,
these reporters require the use of two fluorescent proteins, and therefore use a significant
portion of the visible spectrum (Nguyen and Daugherty, 2005; Xu et al., 1998). As
result, they limit the ability to use additional independent fluorophores to probe signaling
molecules or other cytosolic activities. Such probes might include reporters for the cell
cycle, phosphorylation, and various tagged proteins.
A separate reporter sold by Clontech called the pCaspase-3 sensor is an
alternative genetically encoded caspase reporter (figure 2C,D). This reporter consists of a
nuclear export signal (NES), a DEVD linker, a fluorophore, and a nuclear localization
signal (NLS). After caspase activation, the NES is removed and the reporter relocalizes
from the nucleus and cytosol to the nucleus alone after caspase activation. However one
of the concerns is the various strengths of the NES or NLS in different cells can lead to
improper nuclear localization prior to caspase activation.

34

Variability in Commitment to Apoptosis
Cells destined to undergo apoptosis in response to internal stresses and some
external stresses release cytochrome c and Smac from mitochondria (Ow et al., 2008),
and within minutes activate caspases-3 and -9 (Rehm et al., 2003). In contrast to the
tight timing between these events, the duration of events preceding cytochrome c release
and caspase activation can vary from 1 hour to over 20 hours within a clonal population
of cells (Goldstein et al., 2000).

This variation is striking considering that the

biochemical events within this delayed and variable stage determine whether the cell will
die.
Population variability has also been documented for other phenotypes including
phage lambda infection (Arkin et al., 1998), bacterial chemotaxis (Spudich and Koshland,
Jr., 1976), cell differentiation (Abkowitz et al., 1996; Enver et al., 1998), and HIV-1 Tat
transactivation (Weinberger et al., 2005). Understanding the sources and dynamics of
apoptotic variability can lend insight into the precision with which cells are able to
process extracellular signals.

A number of different factors could contribute to

population variability of apoptosis including differences in the composition of single
cells, the local environment of single cells, or stochasticity in biochemical reactions
triggered by apoptotic stimuli.
One source of in vitro variability in response to an apoptotic drug could be
inhomogeneities in extracellular concentrations of secreted pro- and anti-apoptotic
factors. Apoptotic factors play a role in apoptosis signal transduction in cultured cells
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(Janes et al., 2006). However, it is unclear how much the secreted factor contributes to
the apoptosis variability, or to the shift of apoptosis time of the entire culture. It also
possible that these factors act mainly on the secreted cell itself (Loewer and Lahav,
2006).
A second source of variability could result from stochasticity of the biochemical
reactions in response to apoptotic stimuli. A stochastic transduction of an apoptotic
signal could be the consequence of just a few molecules being involved in a particular
stage of apoptosis (Rao et al., 2002). During apoptosis, factors may re-localize to subcellular regions of the cell including the plasma membrane (Siegel et al., 2004), and the
endoplasmic reticulum (Boehning et al., 2003).

Along with the synthesis and

degradation of molecules (Barkett and Gilmore, 1999; Wertz and Dixit, 2008), this may
create situations where the activation of certain apoptotic factors or complexes may be
limiting, resulting in stochastic onset of apoptosis, and therefore variability in the
population (Raychaudhuri et al., 2008). Thus, even when the same initial conditions are
reproduced, the reaction does not necessarily produce the same result (McAdams and
Arkin, 1998).
A third source of population variability is a heterogeneity of cellular factors amongst
the population (Kaern et al., 2005). In some instances, variation of protein expression has
been correlated to the cell cycle (Sigal et al., 2006a). However, in other instances
variation in protein expression is uncoupled to the cell cycle, and is a function of the time
since cells last shared a common ancestor (Sigal et al., 2006b). The commitment of a
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single cell to apoptosis likely depends on the concentrations and post-translational
modifications to the many molecules involved in apoptosis.
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Chapter Two: Design of Caspase Reporter

Introduction
We first sought to design a probe for caspase-3/7 activity that was genetically
encoded facilitate the generation of stable cell lines and for reporting the caspase activity
in organisms.

Existing reporters for live caspase activity include a reporter which

undergoes a change in Forster Resonance Energy Transfer (FRET) after caspase
activation (Nguyen and Daugherty, 2005; Xu et al., 1998), and another reporter that
transitions from being in both the cytoplasm and the nucleus to being solely in the
nucleus after caspase activation (pCaspase-3 Sensor, Clontech).
The FRET reporter consists of a donor fluorophore and an acceptor fluorophore
which are separated by a DEVD amino acid sequence.

The DEVD sequence is

preferably cleaved by caspase3/7, though is cleaved by other proteases (Thornberry et al.,
1997). Prior to caspase activation, excitation of the donor fluorophore results in emission
from the acceptor fluorophore owing to the close physical proximity of the fluorophores.
After caspase activation and cleavage of the DEVD sequence, the fluorophores are
separated resulting in a change of the emission spectra when the donor fluorophore is
excited. FRET reporters have been used to monitor caspase activation in cell culture
(Nguyen et al., 2007) and in organisms (Takemoto et al., 2007). However, the FRET
reporter requires two fluorophores which limits the use of orthogonal fluorophores for
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simultaneously monitoring other processes. The pCaspase-3 sensor consists of a nuclear
export signal (NES) at its N terminal, followed by the DEVD sequence, a fluorescent
protein, and a nuclear localization signal (NLS). Upon caspase activation, the NES is
removed and the fluorescent protein is exclusively localized to the nucleus. One of the
drawbacks of this reporter is that it depends on strengths of the NES and the NLS in a
particular cell line. This is known to have considerable variation, and in our hands results
in different localization of the reporter prior to caspase activation (data not shown).
In this chapter, we describe the generation and characterization of two
single fluorophore caspase reporters (termed the pmDEVD and erDEVD reporters).
These reporters are based on the principle of re-localization. We compared the kinetics
of these reporters to exiting reporters, and determined the effect on downstream steps of
apoptosis.

Results

Reporter Design
In creating single fluorophore reporters of caspase activity we sought to create
reporters that changed cellular localization upon caspase activity. Two reporters were
constructed: the first reporter was designed to re-localize from the plasma membrane to
the cytoplasm (pmDEVD) (Figure 3), whereas the second reporter relocalizes from the
cytoplasmic surface of the endoplasmic reticulum to the nucleus (erDEVD) (Figure 4).
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The pmDEVD reporter consists of an N-terminal plasma membrane (pm) targeting
palmitoylation domain from Growth Associated Protein 43 (GAP-43) (Skene and Virag,
1989) and a fluorescent protein, which are separated by a linker region containing the
DEVD caspase-3/7 cleavage site (Figure 3A). The linker region contains the amino acid
sequence DEVD that has been used to detect caspase-3/7 activity (Thornberry et al.,
1997). Though other caspases will cleave „DEVD‟ - albeit with a lower efficiency
(Thornberry et al., 1997) - for the sake of consistency of terminology with previous
publications, we refer to the designed DEVDase reporters as a caspase-3/7 reporters. The
pmDEVD reporter was designed so that the fluorophores and the linker region are easily
interchangeable (see plasmid design in Chapter Six).
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Figure 3: Design of the plasma membrane DEVD reporter (pmDEVD). (A) The
reporter consists of a membrane targeted palmitoylation domain (amino acids 1-21
from GAP-43), a linker containing the DEVD amino acid sequence, and a
fluorescent protein (in this case GFP).

(B)

Prior to caspase activation the

fluorophore (green) is localized to the plasma membrane, and after caspase
activation it becomes cytosolic.

The

erDEVD

reporter

contains

the

first

endoplasmic

reticulum

(er)

transmembrane domain of Sec63 as its N-terminus (Meyer et al., 2000) followed by the
DEVD linker region, a fluorescent protein, and finally a triple repeat of the SV40 nuclear
localization signal (NLS) at the C-terminus (Kalderon et al., 1984; Lanford et al., 1986)
(Figure 4). The Sec63 domain consists of amino acids 1-63 of Sec63, and this contains a
protein translocation consensus sequence (Meyer et al., 2000), and a few amino acids
following the transmembrane domain. Similar to the pmDEVD reporter, the fluorophore
in the erDEVD reporter is interchangeable.
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Figure 4: Design of the endoplasmic reticulum DEVD reporter (erDEVD). (A) The
reporter consists of the endoplasmic reticulum translocation domain from Sec63, a
DEVD amino acid sequence, a fluorescent protein (in this case GFP), and a triple
repeat of the nuclear localization tag from SV40. (B) Prior to caspase activation the
fluorophore (green) is localized to the endoplasmic reticulum, and after caspase
activation it becomes localized to the nucleus.

Each reporter is named by its initial localization (er or pm) as well as its
fluorophore. For example, when the mCherry fluorescent protein is linked via the caspase
sensitive sequence DEVD to the plasma membrane, the resulting probe is referred to as
pmDEVD-mCherry. Upon caspase activation the reporters should shift their location
owing to cleavage of the DEVD caspase sensitive linker. As a control for whether the
caspase-sensitive linker region was responsible for any changes in localization, we
created reporters (pmControl or erControl) that only differed from the pmDEVD or
erDEVD reporters by the absence of the DEVD cleavage site in the linker region.
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To test the pmDEVD reporter, we co-expressed the pmDEVD-mCherry and
pmControl-Cerulean reporters in HeLa cells (Figure 5). Prior to any treatment, Golgi
localization of the pmDEVD reporter is observed, which is consistent with earlier
observations of the palmitoylation localization tag (Figure 5A) (McLaughlin and Denny,
1999). After treatment with STS (2 µM), the mCherry fluorescence is relocalized from
the plasma membrane to the cytosol (Figure 5A). This was quantified by monitoring the
fluorescence in a region within the cytoplasm over time (Figure 5B).

In contrast,

pmControl-Cerulean remained at the plasma membrane (images in Figure 5A and
quantification in Figure 5B) indicating that the DEVD cleavage site is responsible for the
change in localization and not the palmitoylation domain. The lack of change in the
pmControl-Cerulean signal also indicates that the contraction of apoptotic cells is not
responsible for the increase in the pmDEVD-mCherry signal.

Thus, the cytosolic

fluorescence of mCherry could be used to quantify the DEVDase activation.
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Figure 5: Time lapse images and quantification of the pmDEVD reporter. (A)
pmDEVD-mCherry and pmControl-mCerulean reporter expressed in the same
HeLa cell and treated with 2μM of STS. The pmDEVD reporter relocalizes to the
cytosol (top panel) and the pmControl reporter remains membrane associated
(lower panel). (B) Quantification of cytosolic fluorescence for the cells in A shows
and increase in the pmDEVD reporter (red diamonds), but no significant change in
the pmControl reporter (blue triangles). Time points with squares correspond to
the images in A.
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Similar results were observed when apoptosis was triggered by the addition of
TNFα (50ng/mL) and cycloheximide (5µg/mL) (data not shown). Notably with TNFα
and CHX treatment, the contraction of the cell occurs approximately 30 minutes after
detectable caspase activity (data not shown). Though these results were observed with
confocal microscopy, a similar increase in fluorescence could be observed with widefield microscopy (Figure 6). With wide-field microscopy, prior to any treatment, there is
an apparent cytosolic fluorescence which is likely out of focus plasma membrane
associated fluorescence. When treated with STS (2 μM), there was an increase in the
cellular fluorescence of the cell as the probe was released from the plasma membrane.
This net increase in fluorescence suggests that the reporter may be at a high enough
density at the plasma membrane to partially self-quench. Alternatively, this may indicate
out of focus fluorescence entering the focal plane.
To test the utility of the erDEVD reporter, we transfected HeLa cells with the
erDEVD-mCherry reporter and the erControl-mCerulean reporter, and treated cells with
TNFα (50ng/mL) and CHX (5µg/mL) (Figure 7). While the mCherry fluorescence relocalized to the nucleus (Figure 7A upper panel; Figure 7B red trace), no change was
seen in the localization of the erControl-Cerulean reporter (Figure 7A lower panel, 7B
blue trace). Therefore, in both the pmDEVD and the erDEVD reporters, the linker region
was responsible for the re-localization of the fluorophore during induction of apoptosis.
Similar results were observed in cells treated with STS (2µM) (data not shown).
Notably, the erDEVD reporter does not completely relocalize from the ER to the cytosol
after caspase activation. This could indicate that the reporter is inaccessible at the plasma
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membrane. Inaccessibility could also be an issue of the pmDEVD reporter, but would
not be detectable owing to the cytosolic (and not nuclear) relocalization which would
mask the presence of some plasma membrane fluorescence.

Figure 6: Time lapse images and quantification of the pmDEVD reporter in
widefield microscopy. (A) pmDEVD-mCherry expressed in HeLa cells and treated
with 2μM of STS.

Caspase activation is indicated by an increase in total

fluorescence. (B) Quantification of cytosolic fluorescence for the cells in (A) shows
and increase in fluorescence of pmDEVD reporter.
correspond to the images in A.
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Time points with squares

Figure 7: Time lapse images and quantification of the erDEVD reporter.

(A)

erDEVD-mCherry and erControl-mCerulean reporter expressed in the same HeLa
cell and treated with 2μM of STS. The erDEVD reporter relocalizes to the nucleus
and the erControl reporter remains associated with the ER. (B) Quantification of
nuclear fluorescence for the cells in A shows and increase in the pmDEVD reporter
(red diamonds), but no significant change in the pmControl reporter (blue
triangles). Time points with squares correspond to the images in A.
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Comparison to Existing Reporters
We next compared the developed re-localization reporters to existing reporters on
the basis of signal strength and kinetic sensitivity. One existing reporter has a caspase3/7 targeted DEVD linker between two fluorophores and yields a change of FRET upon
caspase activity (FRET-DEVD) (Nguyen and Daugherty, 2005). This reporter consist of
the fluorophores CyPet and yPet which were optimized FRET fluorophores derived from
CFP and YFP respectively (Nguyen and Daugherty, 2005). A second existing reporter
has a fluorescent protein and a nuclear localization signal (NLS) which are separated by
DEVD linker from a nuclear export signal (NES). This reporter localizes to the nucleus
upon activation of caspase-3/7 and removal of the nuclear export signal (pCaspase-3
sensor, Clontech).

To compare the signal strength properties of the reporters, we monitored both the
fold increase of the signal of the reporters in different cells, and determined the ratio of
magnitude of the increase relative to the noise of the initial signal (n>10 cells). The fold
increase of the pmDEVD reporter (4.5±1.9) was similar to the erDEVD reporter
(4.2±1.5), but was significantly greater than the increase of the pCaspase-3 and FRET
reporters (2.2±0.7, p=0.003, and 2.4±0.4, p=0.0006 respectively) (Figure 8).
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Figure 8: Comparison of the fold increase properties of the different reporters. The
pmDEVD reporter shows the largest fold increase, and the erDEVD reporter is
within error. By comparison the pCaspase-3 sensor and the FRET sensor show less
of an increase (p=0.003 and p=0.0006 respectively).
standard deviation.
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All error bars represent

We next wanted to assess the signal to noise ratio of the reporter which gives an
approximate measure of the dynamic range of the reporter. The signal to noise is defined
as the increase in fluorescence divided by the standard deviation of the reporter signal
prior to caspase activation (Figure 9A). The pmDEVD has the highest ratio (80±50), and
erDEVD has the second lowest ratio (65±34). The ratios of the pCaspase-3 sensor and the
FRET-DEVD (39±9, and 22±11 respectively) reporter are significantly smaller than the
pmDEVD ratio (P=0.009 and P=0.0007 respectively) (Figure 9B). Thus in comparing
the reporters on their fold increase an in the signal to noise ratio, the pmDEVD reporter
showed better signal strength than the pCaspase-3 sensor and the FRET reporter.
The reporters were next compared based on the kinetics of their response:
specifically the time of the first detectable signal of the reporters, and the time to the halfmaximum point of the activity curves. The first detectable signal was quantified as the
time when the signal was two standard deviations above the noise of the basal signal. In
all cases we made kinetic comparisons between different reporters expressed
simultaneously in the same cell, to avoid potential variability between cells. Possible
variability could result from the amount of caspase present in different cells or the degree
of caspase activation from cell to cell. We induced apoptosis in cells transfected with
both the pmDEVD and FRET-DEVD reporter, or in cells expressing the pmDEVD,
erDEVD and pCaspase-3 reporters simultaneously and quantified the signal of each.
Example kinetic traces of the simultaneous use of these reporters are shown in Figure 10.
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Figure 9: Comparison of the signal to noise of the different reporters. (A) Signal to
noise is calculated as the standard deviation of the ten points before caspase
activation divided by the fold increase. (E) Comparison of signal to noise for the
different reporters. The pmDEVD has the highest ratio (80±50), and erDEVD has
the second lowest ratio (65±34). The ratios of the pCaspase-3 sensor and the FRETDEVD (39±9, and 22±11 respectively) reporter are significantly smaller than the
pmDEVD ratio (p=0.009 and p=0.0007 respectively).
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Figure 10: Comparison of the different reporters in the same cell. To check the
differences in the kinetics of the reporters we made comparisons of reporters in the
same cell. (A) Kinetics of a pmDEVD (red triangles) and FRET-DEVD (yellow
circles) reporter in the same cell. The reporters show similar kinetics. (B) Kinetics
of the pmDEVD (red triangles), erDEVD (yellow squares) and pCaspase-3 (blue
circles) reporters expressed in the same cell shows slightly differences in kinetics of
the reporters.
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Figure 10
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The first detectable caspase activation signal was consistently observed with the
pmDEVD reporter (Figure 11).

We therefore made comparisons of the pmDEVD

reporter to each of the other reporters. There was a time lag between the pmDEVD and
the erDEVD reporter (100±41s for first detectable signal, and 247±118s to halfmaximum activation). The pCaspase-3 sensors were significantly delayed relative to the
pmDEVD reporter (delay to first detectable signal = 154±80s, delay to half-maximum =
186±133s). For the FRET-DEVD reporter the delay to the first detectable signal
(31.9±88s) or to half-maximum (141±169s) was not statistically significant. Therefore,
the pmDEVD reporter preserves the kinetic properties of the FRET-DEVD reporter,
while only using a single fluorophore, and having a larger fold increase in the signal.
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Figure 11: Quantification of the kinetic properties of the different reporters, (A)
The first detectable signal of the pmDEVD reporter was observed before the
erDEVD reporter (100±41seconds), the pCaspase-3 sensor (154±80 seconds), and at
the same time as the FRET reporter (31.9±88 seconds). (B) The pmDEVD reporter
reached the half-maximum faster than the erDEVD reporter (247±118 seconds), the
pCaspase-3 sensor (186±133 seconds). For the FRET-DEVD reporter the delay to
half-maximum (141±169 seconds) was not statistically significant. All error bars
represent standard deviation.
55

To determine that the release of the reporter coincides with other apoptotic events,
we monitored the release of cytochrome c-GFP along with the pmDEVD reporter.
Observations of the release of mitochondrial proteins suggest that caspase activation
occurs approximately 10 minutes before caspase activation (Rehm et al., 2003). We
expressed the pmDEVD-mCherry reporter in HeLa cells along with cytochrome c-GFP
and induced apoptosis with 2μM of STS. Cytochrome c release from mitochondria
occurred before the detected pmDEVD caspase activation (Figure 12A). We quantified
the release of cytochrome c release by monitoring the standard deviation of the pixels
divided by the total intensity (referred to as the punctuate diffuse index) (Figure 12B).
Thus when cytochrome c is aggregated in mitochondria, the standard deviation should be
high, and when released, the standard deviation should decrease. This quantification also
demonstrated cytochrome c-GFP release occurred a few minutes before caspase
activation (Figure 12B).
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Figure 12: Release of cytochrome c-GFP and pmDEVD-mCherry in the same cell.
HeLa cells treated with 2µM STS. (A) Images of cytochrome c release (top panel)
and caspase activation (lower panel).

(B) Quantification of the release of

cytochrome c-GFP (green) measured as the standard deviation/total intensity of the
cell, and cytosolic mCherry fluorescence (red). Squares indicate data points
corresponding to the images in A.
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Effect of pmDEVD on the Progression of Apoptosis
A potential concern with any reporter is that it might perturb the event that it is
designed to assay. To determine whether the expression of the pmDEVD reporter, which
is a caspase-3 and -7 target, would affect the progression of apoptosis, we assayed
whether expression of pmDEVD delayed chromatin condensation – an event downstream
of caspase-3/7 activation (Liu et al., 1997). Cells were transiently transfected with the
pmDEVD reporter, treated with STS (2µM), fixed at different time points, and were
stained with TUNEL – which marks apoptotic cells.

Expression of the pmDEVD

reporter had no detectable effect on the kinetics of TUNEL staining (Figure 13). This
result illustrates that the pmDEVD reporter records the kinetics of caspase-3/7 activation
without a detectable effect on subsequent apoptotic steps.
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Figure 13: Test of potential effects of the pmDEVD reporter on DNA fragmentation.
Cells were transiently transfected with the pmDEVD reporter, treated with
staurosporine (2µM), fixed at different time points, and were stained with TUNEL.
Percentage of dead cells transfected with pmDEVD-mCherry (red square);
Percentage of dead untransfected cells (yellow circle). Each data point represents
the average from three wells − with >50 cells analyzed per well.

Summary
We created two reporters for assaying caspase activity in single cells. One
of the reporters relocalizes from the plasma membrane to the cytosol (pmDEVD), and the
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other reporter relocalizes from the ER to the nucleus (erDEVD) (Figure 3,4). Each
reporter requires the use of only a single fluorophore, and is genetically encoded which
enables use in organisms and the creation of stable cell lines. In comparing the signal
strength and kinetic properties of each of the reporters, we find that the pmDEVD
reporter had similar kinetic properties to the FRET reporter, but showed a greater signal
increase (Figures 8-11).

We also demonstrate that the pmDEVD reporter can be

monitored with confocal or widefield microscopy in single cells (Figures 5,6). This
probe reports activity after cytochrome c release which is consistent with existing data,
and does not have an effect on DNA fragmentation (as assayed by TUNEL staining)
which is downstream of caspase activity (Figure 13). This suggests that the pmDEVD
reporter assays caspase activity without noticeably affect the progression of apoptosis.
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Chapter Three: Similarity of Sister Cell Apoptosis
Introduction
Cells destined to undergo apoptosis in response to internal stresses and some
external stresses release cytochrome c and Smac from mitochondria (Ow et al., 2008),
and within minutes activate caspase-3 and caspase-9 (Rehm et al., 2003). In contrast to
the tight timing between these events, the duration of events following exposure to an
apoptotic agent but preceding cytochrome c release and caspase activation can vary from
1 hour to over 20 hours within a clonal population of cells (Goldstein et al., 2000). This
variation is striking considering that the biochemical events within this delayed and
variable stage determine whether the cell will die or survive.

Population variability has also been documented for other phenotypes, including
phage lambda infection (Arkin et al., 1998), bacterial chemotaxis (Spudich and Koshland,
Jr., 1976), cell differentiation (Abkowitz et al., 1996; Enver et al., 1998) and HIV-1 Tat
transactivation (Weinberger et al., 2005). Understanding the sources and dynamics of
apoptotic variability can lend insight into the precision with which cells are able to
process extracellular signals. A number of different factors could contribute to population
variability of apoptosis, including differences in the composition of single cells, the local
environment of single cells, or stochasticity in biochemical reactions triggered by
apoptotic stimuli.
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Here, we observe that when and whether cells entered apoptosis were
synchronized between cells in close proximity. Entry into apoptosis did not correlate with
the distance between unrelated cells, or with the phase of the cell cycle. Entry into
apoptosis was strongly correlated for sister cells, and this correlation diverged over
subsequent generations. The divergence of apoptosis times was inhibited by blockade of
protein synthesis. These results indicate that there is a persistent cellular state underlying
the susceptibility of a single cell to apoptosis. These results are similar to a separate
study published while our work was in review (Spencer et al., 2009).

Results

Neighboring Apoptosis
To gain insight into the cell-to-cell variability in the onset of apoptosis, we
developed HeLa cell lines that stably expressed the pmDEVD-mCherry caspase-3/7
reporter and a nuclear marker (YFP-NLS) to facilitate cell tracking. Using wide-field
microscopy, we monitored cellular fluorescence in cells that were plated 40 hours prior to
treatment with STS (2µM). Cells were imaged every 5 minutes with a 10x objective
using an Olympus IX81 widefield microscope. The onset of caspase-3/7 activation was
indicated by a large increase in cellular fluorescence of pmDEVD-mCherry when
observed by wide-field microscopy (Figure 14A: mCherry false colored green, YFP-NLS
false colored blue). A map of nuclei which are color coded to represent the time of
62

caspase-3/7 activation indicates that groups of spatially clustered cells undergo apoptosis
at similar times, and thus a localized synchronization of apoptosis (Figure 14B).

To quantify the local synchronization of caspase-3/7 activation observed in Figure
14 for all pairs of cells we plotted the difference in the time of caspase-3/7 activation as a
function of the distance between cells. When cells were closer to each other it was more
likely that their caspase activation would be synchronized (Figure 15C - blue). To
determine potential artifacts of the analysis that could generate a spatial correlation, we
randomly reassigned apoptosis times to different cellular positions and no correlation was
reported, thus demonstrating that the analysis did not contribute to the spatial correlation
between caspase-3/7 activation and intercellular distance (Figure 15C - red).
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Figure 14: Local synchronization of apoptosis. (A) HeLa cells expressing pmDEVDmCherry (green) and YFP-NLS (blue) treated with 2μM of STS. Onset of DEVDase
activation is marked by the increase in fluorescence. (B) Nuclei of HeLa cells in A.
Nuclei are color coded to represent the times of apoptosis. Clusters of cells with
white outlines indicate examples of neighboring cells undergoing DEVDase
activation at similar times.
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Figure 14
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Figure 15: Plot of the difference in time of apoptosis between HeLa cells as a
function of their distance reveals a correlation between apoptosis and distance.
(Error bars represent 95% confidence interval of the mean.)
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The following are three possibilities that could explain the correlation of the
distance between cells and the time of caspase activation: First, cells that are near each
other may be sister cells which are at a similar phase of the cell cycle. If there is a cell
cycle dependant susceptibility to apoptosis this could account for the local
synchronization of the activation of caspases. Second, cells may secrete factors that
promote or hinder apoptosis in a local neighborhood. Third, sister cells may have similar
molecular compositions uncoupled from the cell cycle that affects their sensitivity to
entering apoptosis.

Cell Cycle and Apoptosis Correlation
To investigate the role of the cell cycle in locally synchronized apoptosis, we
monitored fluorescent reporters for both apoptosis and the cell cycle stage in single cells.
Two approaches were taken. The first was to synchronize the cell cycle. HeLa cells
expressing pmDEVD were subjected to a double thymidine block (15 hr block, 10 hr
release, 15 hr block), and released for variable intervals before treatment with STS
(2µM). No correlation was observed between the time to apoptosis and the time cells
were treated after release (One way ANOVA: F=1.26 < Fcrit=2.40; Figure 16).

67

Figure 16: Cell Cycle Synchronization Experiment. HeLa cells expressing pmDEVD
were subjected to a double thymidine block (15 hour block, 10 hour release, 15 hour
block), and released for variable intervals before treatment with 2 µM STS. No
correlation was observed between apoptosis and the time cells were treated after
release. One way ANOVA performed to determine significant differences between
apoptosis at different time points. F=1.26<Fcrit=2.40; therefore there is no
significant difference between inducing apoptosis at different times after release
from a double thymidine block.

One potential concern of the cell cycle synchronization experiment is the effect of
cell cycle synchronizing agents on apoptosis (Ji et al., 1997), which might mask a cell
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cycle sensitivity. Thus, the second approach was to observe an asynchronous population
in which the state of the cell cycle could be characterized in each individual cell with a
fluorescent reporter. For this purpose we observed the G1/S cell cycle transition using a
fluorescent fusion to the PSLD domain of human DNA Helicase B (referred to as PSLDmCitrine) (Gu et al., 2004; Taneja et al., 2002). This PSLD-mCitrine reporter is localized
to the nucleus in G1 phase and transitions to the cytosol upon cyclinE CDK
phosphorylation, which marks the G1/S transition (Gu et al., 2004) (Figure 17) .

Figure 17: PSLD-mCitrine cell cycle reporter. This reporter transitions out of the
nucleus owing to cyclin E-CDK2 phosphorylation at the G1/S transition. It begins
in the nucleus in G1 phase , then transitions to being in both the nucleus and the
cytoplasm during the G1/S transition, and the reporter becomes cytosolic in the
S/G2 phase.

To facilitate identifying and tracking individual cells we used a Cerulean-NLS as
a nuclear marker. The nuclear fluorescence was determined by tracking Cerulean-NLS
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using the Spot Module in Imaris. A mask of the Cerulean NLS fluorescence was created
and the PSLD-mCitrine fluorescence was monitored in that mask. An example of the
quantification of PSLD-Citrine nuclear fluorescence is shown in Figure 18 A and B.
Here a mother cell (green trace) divides into two daughter cells (blue and red trace), both
of which undergo the G1-S transition. At time t=1.8 hours the mother cell enters M
phase − the fluorescence associated with the nuclear marker increases owing to a
breakdown of the nucleus and rounding of the cell. The cell divides at time t=3.5 hours,
and later at approximately t=9 hours, the cells start to undergo the G1-S transition,
resulting in a decrease of nuclear fluorescence.

The duration of G1 phase was

determined by the time difference between division, and the decrease in nuclear
fluorescence of the PSLD-Citrine. A histogram was created for n=143 cells. The duration
is 4.7±2.3 hours (standard deviation) indicating considerable variability in the duration of
G1 (Figure 18C).
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Figure 18: Quantification of the PSLD cell cycle reporter. (A) The PSLD-mCitrine
nuclear fluorescence of the mother cell is indicated by the green line; the nuclear
fluorescence of the daughter cells is indicated by the red and blue lines. At time
t=1.8 hours the mother cell enters M phase and the cell divides at time t=3.5 hours.
At approximately t=9 hours, the cells start to undergo the G1-S transition, resulting
in a decrease of nuclear fluorescence. (B) Fluorescence images corresponding to the
quantification in A. (C) The duration of G1 phase was determined by the time
difference between division, and the decrease in nuclear fluorescence of the PSLDCitrine. A histogram was created for n=143 cells. The duration is 4.7±2.3 hours
(standard deviation) indicating considerable variability in the duration of G1.
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To monitor both the stage of the cell cycle and the onset of caspase activation we
co-expressed Cerulean-NLS, PSLD-Citrine and pmDEVD in HeLa cells and treated cells
with 2 µM STS (Figure 19). Here, the nuclear outline in the upper panel indicates the
mask created by the Cerulean-NLS fluorescence. We tracked cells for several hours prior
to the addition of STS (time t=0 indicates when STS is added). The activation of caspase3/7 is indicated by an increase in fluorescence (Figure 19 – lower panel).

Figure 19: Monitoring the cell cycle and caspase activity in the same cell. (Top
Panel) Expression of the PSLD-mCitrine cell cycle reporter. Cells transition out of
G1 (nuclear to cytosolic localization).

(Bottom Panel)

Caspase activity of the

pmDEVD mCherry reporter indicated by the increase in fluorescence.
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The phase of the cell cycle was determined relative to either the G1/S transition,
or the time of last division. The time of apoptosis was plotted as a function of the
position in the cell cycle at the time of STS treatment since the reporter becomes
localized in both the nucleus and cytoplasm after STS treatment. No correlation could be
detected between the phase of the cell cycle at the time of STS addition, and the time of
caspase activation after treatment with STS (Figure 20). These results indicate that the
correlation of the distance between cells and when cells enter apoptosis in response to
STS is not related to the cell cycle.
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Figure 20:

Correlation of the stage of the cell cycle and the onset of caspase

activation in single cells. HeLa cells expressing the PSLD-mCitrine reporter and the
pmDEVD-mCherry reporter were monitored to determine the stage of the cell cycle,
then treated with 2μM of STS. There was no clear correlation between the phase of
the cell cycle at the time of treatment and the time to caspase activation.
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Separation of Distance and Genealogy
To determine if the local synchronization in activation of caspases was the effect
of secreted factors or of a similarity of molecular composition of sister cells, we
performed three different tests. The first test was to monitor the activation of caspase in
the rapidly moving HT1080 cell line that was stably expressing pmDEVD-mCherry and
YFP-NLS. HT1080 migrate after division such that average distance between nuclei of
sister cells was 223±39 µm (compared to 66±13 µm for HeLa pairs; Figure 21). In the
HT1080 cells there is a lower probability that neighboring cells are also sister cells which
would uncouple effects of possible secreted factors from similarities in the molecular
composition of the cell. The rapid movement also created situations where a pair of sister
cells were separated by an unrelated cell. In these situations we determined whether the
time of caspase activation in each sister cell was correlated with the nearer unrelated cell
or the more distant sister cell.
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Figure 21: Distance correlation for the HT1080 cell line. (A) A histogram of the
distance between sister cells at the time of drug treatment indicates that the distance
between HT1080 sister cell pairs is larger than the distance between HeLa cell pairs.
The average distances are 223±39 µm for HT1080 cells, and 66±13 µm for HeLa
cells.

An example of HT1080 sister cells that are separated by other cells at the time of
STS (2μM) treatment is shown in Figure 22A.

While the sister cell pair undergo

apoptosis at similar times, a cell that had migrated so that it was between the sister cells
does not undergo apoptosis until much later (Figure 22B).
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Figure 22: (A) Time lapse images of HT1080 cells before and after treatment with
STS. T=0:00 indicates the time of STS addition. HT1080 cells express the pmDEVD
caspase-3/caspase-7 reporter (grey-scale), and YFP-NLS (shown as a colored
nuclear outline). An instance of sister cells that are physically separated is indicated
by cells with a red nuclear outlines. The separating cell is indicated with a yellow
nuclear outline. All other nuclei are in blue. (B) Time course of caspase-3/caspase-7
activation of the sister cells in (A), and a cell between the sister cells. Color of the
data points corresponds to cells with the same colored nuclear outline in (B). Cells
undergo apoptosis at a similar time relative to the distribution of apoptosis, and
relative to the middle cell.
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Figure 22
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Furthermore, for HT1080 cells, there was no correlation between inter-cellular
distance and the onset of apoptosis (Figure 23). This suggests that a secreted factor
cannot be entirely responsible for the correlation between caspase activation and distance.
However this does not exclude the partial contribution of secreted factors to the
correlation seen in HeLa cells (Figure 14).

Figure 23: Plot of the difference in time of apoptosis between HT1080 cells as a
function of their distance. (n=195 cells in three fields). Error bars represent 95%
confidence interval of the mean.
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The second test was to uncouple distance and genealogy by dissociating cells
from their dish, and then re-plating them so their positions are randomized (Figure 24). If
the genealogical relationship between cells was responsible for the local synchronization
of apoptosis, then when cells were dissociated and then re-plated at a high density, the
local effects should be lost.

In contrast, effects of secreted factors on neighboring

apoptosis should be unaffected.

Figure 24: Scheme of plating experiments. Cells in which apoptosis is induced
shortly after plating are unlikely to be related; by comparison cells that are treated
with a drug long after plating are more likely to have divided and thus be related.
Cells of similar colors are related cells.

Cells that were plated 48 hours or 80 hours prior to STS treatment showed a
strong distance correlation (Figure 25): The delay between two cells entering apoptosis
that were 50 µm apart was 24% less than cells 200 µm apart for cells plated 48 hours
prior to treatment.

However, for cells plated 14 hours prior to STS treatment, the

decrease in the delay for entering apoptosis for cells at a distance of 50 µm was reduced
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only 8%, indicating a weaker local effect. This residual degree of synchronization could
be due to the presence of a few neighboring sister cells which divided within 14 hours
after plating (data not shown).

Figure 25: Analysis of time difference of DEVDase activation as a function of
distance for cells plated at various times prior to STS addition (number of cells>385
for each time point).

The third test was to separate the effects of HeLa cell genealogy and inter-cell
distance by determining the correlation between caspase-3/7 activation and distance after
excluding comparisons between related HeLa cells. Cells at closer distances demonstrate
a higher similarity of their times of caspase-3/7 activation than cells further apart
indicating a correlation between caspase-3/7 activation and distance (Figure 26 - red).
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However, when sister cells were excluded from the comparison the correlation was
weaker (Figure 26 - green) and further weakened when sister and cousin cells are
excluded (Figure 26 - purple). To determine whether the spatial correlation to apoptosis
was only between sister cells, we plotted time of caspase-3/7 activation between sister
cells as a function of their inter-cell distance (Figure 26 - blue). While these showed a
high degree of similarity between time of entering apoptosis, they did not show
correlation with distance. The lack of spatial correlation between sister cells further
indicates that a secreted factor between sister cells does not contribute to the correlation
between caspase activation and intercellular distance. The combination of the above
experiments suggests that secreted factors do not play a role that we can detect in the
local synchronization in the activation of caspases.
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Figure 26: Analysis of the time difference of DEVDase activation as a function of
distance between cells for sister cell cells (blue), between all cells (red), between all
cells that are not sister cells (green), and between all cells that are not sister cells or
cousin cells (purple) (n=562 cells in three fields).

Similarity of Apoptosis Timing Between Sister Cells
The observation that in unrelated cells there is no correlation between distance
and when cell undergoes apoptosis implicates cell lineage and an underlying source for
the local synchrony of apoptosis. This was further tested by quantifying the difference in
caspase activation between sister cells (Figure 27 - blue). As a control we measured the
distribution of the differences in the time of caspase activation between randomly paired
cells (Figure 27 – red). When HeLa cells were treated with STS (2µM), the difference in
83

caspase-3/7 activation between randomly paired cells was significantly greater than the
difference in caspase-3/7 activation between sister cells (p=6.2x10-34; Figure 27). This is
an independent confirmation of the role of lineage in determining when a cell undergoes
apoptosis.

Figure 27: Histogram of the difference in time of DEVDase activation between HeLa
sister cells, and between randomly paired cells (n=265 pairs).

To determine whether the similarity in apoptosis times between sister cells was
specific to a cell type or apoptotic stimuli, we calculated the average difference in the
onset of caspase-3/7 activation between sister cells, and between randomly paired cells
for HeLa, NIH3T3, HT1080, and mouse embryonic fibroblasts (MEF) cells. These cells
were treated with STS (2μM), TNFα (250μg.mL) + CHX (5μg/mL), or etoposide (ETO,
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50μM) (Figure 28). In all cases the average time difference of caspase-3/7 activation
between sister cells was significantly less than the average time difference of caspase-3/7
activation between randomly paired cells. These results, obtained in multiple cell types
and with multiple drugs, indicate that the similarity of caspase-3/7 activity between sister
cells is not a cell type specific or drug-specific effect.

Figure 28: Average difference in DEVDase activation between sister cells (blue), and
randomly paired cells (red) for HeLa, NIH3T3 and HT1080 cells treated with 2 µM
STS, 250 ng/µl TNF + 5 µg/ml CHX, or 50 µM ETO. Differences between sister
and random distributions are significant for all cell types (STS: HeLa, P=6.2x10–34;
3T3, P=0.0011; HT1080, P=2.1x10–10; MEF, P=9.9x10–4. TNF +CHX: HeLa,
P=1.4x10–16; 3T3, P=4.7x10–14; HT1080, P=5.8x10–10. ETO: HeLa, P=1.2x10–11. For
MEFs, npairs=21; for all other cells: npairs is between 54-106 pairs for different
conditions).
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Similarity of Sister Cell Fate
To determine whether the cellular fate was similar between sister cells, we used a
milder apoptotic treatment which only killed a fraction of cells, and determined whether
both sister cells underwent apoptosis or survived, or whether only one of the sister cells
underwent apoptosis. HeLa cells were transiently treated with of STS (1µM) for 45
minutes, and during the subsequent 36 hours, 44% of the cells underwent apoptosis. If
there was no linkage in the fate between sister cells, then of 72 total cell pairs, 14 pairs
should both undergo apoptosis, 22 pairs should both survive, and 36 pairs should have
only one cell undergoing apoptosis (Figure 29 - red). Instead we observed that 27 sister
pairs both underwent apoptosis, 35 pairs both survived, and there were 10 pairs where
only one cell underwent apoptosis (Figure 29 - blue). Of the cells that did not undergo
apoptosis, a few did not divide again, and it is possible that even 36 hours after treatment,
apoptosis will still continue to occur. Nonetheless, given that 44% of all cells die, the
probability that there are only 10 pairs of sister cells of which only one undergoes
apoptosis is p<0.0005 ( 2= 37.2, 2 degrees of freedom). This indicates that not only the
timing of apoptosis between sister cells is similar (Figure 27), but also when given a mild
apoptotic treatment, the fates of sister cells are similar (Figure 29).
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Figure 29: HeLa cells treated with 1 µM STS for 45 minutes. In blue are counts of
sister cell pairs where both cells die, only one cell dies and where both survive. In
red is the expected value of the counts if there were no apoptosis similarity between
sister cells, and given that 44% of all cells underwent apoptosis. All error bars
represent the 95% confidence interval of the mean.

Intergenerational Divergence of the Apoptosis Susceptibility
The similarity of the apoptosis between related cells could be stable – resulting
from the inheritance of genes. Thus the similarity of whether and when related cells
undergo apoptosis could result from the presence of a mixture of difference cell lineages.
However, the similarity could also be transient – arising from the division of proteins
from the mother cell. Alternatively, the similarity may be a combination of these factors.
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To distinguish between these possibilities, we monitored the lineage of cells up to four
generations prior to apoptosis treatment. We reasoned that if the similarity resulted from
a temporary inheritance of proteins, then the difference in the time of caspase-3/7
activation between two cells should become larger as the cells are more distantly related.
Alternatively, if it were a stable genetic alternation, then the differences in the time of
caspase activation should remain constant for the different lineages. To assay differences
and similarities in apoptosis susceptibility for a time longer than four generations, we
created clonal cell lines and compared the distribution of the time of caspase-3/7
activation between these lines. If similarity of apoptotic state resulted from a stable
genetic inheritance, we expected a significant difference in the time of caspase-3/7
activation between different cell lines. We monitored cells for up to 90 hours prior to
apoptosis treatment to determine the lineage of cells. We defined sister cells as being one
generation apart and cousin cells as being two generations apart (Figure 30).
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Figure 30: Lineage of cells. We monitored cells for up to 90 hours prior to apoptosis
treatment to determine the lineage of cells. We defined sister cells as being one
generation apart and cousin cells as being two generations apart.

After monitoring the lineage of HeLa cells for four generations, we treated cells
with STS (1 µM) and compared the time of apoptosis between cells that shared a
common ancestor (Figure 31). A histogram of the apoptosis time differences, as well as
the apoptosis time difference between randomly paired cells is shown in Figure 31. As
the relation between cells becomes more distant (from gold, to green to blue to red), the
histogram flattens, approaching the histogram of randomly paired cells (Figure 31).
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Figure 31: Divergence of apoptotic susceptibility. (A) The difference in time of
apoptosis between cells from different generations. As the number of generations
between cells increases, the curve flattens.

To determine the dynamics of the divergence of the apoptotic susceptibility, we
fit the mean difference of the time to enter apoptosis between cells from different
generations to an exponential recovery curve (Figure 32). This curve was selected on the
assumption that cells lost a proportional fraction of their apoptotic susceptibility during
division or over time. The fit was of the form y=42.5+43.2(1–e–(g–1)/1.94) with y minutes,
and g in generational difference between cells. Analysis of the fitted parameters revealed
that the half-time of loss of apoptosis susceptibility was 1.3±0.6 generations, and as cells
become more distantly related, the difference in their time of apoptosis approaches the
asymptote of 86±9 minutes. The calculated half-time is similar to half-times of the
mixing of gene expression in related mammalian cells (Sigal et al., 2006b), suggesting
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that the similar apoptosis times of sister cells may reflect the similarity of gene
expression levels.

Furthermore, the calculated time of apoptosis between distantly

related cells (86±9 min) is within error of the measured apoptosis time differences
between unrelated cells (90±1 min), indicating that the similarity of the apoptotic state of
related cells is transient, and does not result from genetic differences.

Figure 32: Analysis of the difference in DEVDase activation between cells from
different generations and between unrelated cells (blue circles). Cells are fit to an
exponential recovery curve (solid red line). Exponential fit is: y=42.5+43.2(1–e–(g–
1)/1.94

) with y minutes, and g in generational difference between cells; R2=0.988 for

the shown data points. Red dotted line is the asymptote of exponential recovery fit.
Pink overlay is the error of the asymptote.
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To examine the persistence of apoptosis susceptibility over more than four
generations, we analyzed the distributions of the onset of caspase-3/7 activation in clonal
cell lines (Figure 33).

The overlap in the distributions was significant (One way

ANOVA: F=1.29, Fcrit=2.38, F>Fcrit) indicating that the similarity in apoptosis
susceptibility does not persist indefinitely, and is unlikely a result of genetic variation or
the presence of multiple cell lineages.

Figure 33: Kinetics of apoptosis in clonal populations. Clonal cells expressing the
pmDEVD-mCherry reporter treated with 2 μM STS.
apoptosis was similar according to One Way ANOVA.
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Overall distribution of

Intragenerational Apoptosis Divergence
To gain insight into the divergence of apoptosis susceptibility, we plotted the
difference in caspase activation as a function of the time since sister cells or cousin cells
divided from their last common ancestor (Figure 34). An exponential recovery curve was
fit to the data; this was of the form: y=5.8+68.5(1–e–t/1256). To assess intragenerational
trends, cell pairs were binned according to the time since division (500 minute bins;
Figure 34). We found that apoptosis times between newly divided sister cells was more
similar than sister cells that had divided long before STS treatment (1μM STS – Figure
34). Thus, the varied susceptibility to apoptosis is a function of the time that cells spend
apart. These results indicate that the loss of correlation of apoptosis between sister cells
occurs continuously and not as a discrete step during mitosis, or another phase of the cell
cycle.
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Figure 34: Difference in DEVDase activation between related cells (sister cells,
green; cousin cells, red) as a function of time since cells shared a common ancestor.
Recovering exponential fit (blue line), confidence interval of fit (yellow line) are
plotted as well as individual time points from a 500 minute binning (black squares).
Exponential fit is: y=5.8+68.5(1–e–t/1256) with y and t in minutes; R2=0.122.

Inhibition of Divergence
One possibility for the divergence of apoptosis susceptibility in sister cells is a
difference in gene expression after division.

To determine whether new protein

expression was responsible for the divergence of apoptosis susceptibility, we inhibited
protein expression in newly divided cells using cycloheximide (CHX) - an inhibitor of
protein translation (ENNIS and LUBIN, 1964; SIEGEL and SISLER, 1963). We sought
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to inhibit protein synthesis prior to apoptosis treatment but after cell division, Thus in an
asynchronous culture we monitored newly divided HeLa cells under the following
conditions: (1) in the presence of CHX (20 µg/mL) for 9 hours, (2) in the absence of
CHX for 3 hours, followed by the presence of CHX for 6 hours, (3) in the absence of
CHX for 6 hours, followed by the presence of CHX for 3 hours, and (4) in the absence of
CHX for 9 hours. Cells were then treated with CHX (20 µg/mL) and STS (1µM) (Figure
35).

Figure 35: Schematic of the protein inhibition experiment. (1) in the presence of
CHX (20 µg/mL) for 9 hours, (2) in the absence of CHX for 3 hours, followed by the
presence of CHX for 6 hours, (3) in the absence of CHX for 6 hours, followed by the
presence of CHX for 3 hours, and (4) in the absence of CHX for 9 hours. Cells were
then treated with CHX (20 µg/mL) and STS (1µM)
The difference in apoptosis times was determined for sister cells. We plotted the
histograms of the time difference of apoptosis between sister cells. The longer time that
sister cells spent in the absence of CHX, the greater the difference in apoptosis times
(Figure 36A,B).

The difference in sister cell apoptosis times for different CHX
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treatments was not a result of an overall difference in the time of apoptosis in the
population (Figure 36C).

Figure 36: Difference in DEVDase activation between newly divided sister cells for
different treatments with cycloheximide (see text). Relative to untreated cells, the
difference is smaller for cells in CHX for 9 hours (P=0.0039). Error bars represent
95% confidence intervals
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One of the concerns of using cycloheximide is that it may have a non-specific
effect that may alter another aspect of apoptosis. Thus we sought to inhibit protein
synthesis with another inhibitor to determine if we got the same effect. Similar results
were also observed with puromycin, another inhibitor of protein synthesis that works
through a different mechanism from cycloheximide (Traut and Monro, 1964) (Figure 37).
We could only extend the pre-treatment of cells in puromycin to 6 hours since at 9 hours,
some cell death started to occur without STS treatment (data not shown). These results
suggest that the divergence of apoptosis times between sister cells is partially a result of
new protein expression.

Summary
In this chapter we provide experiments demonstrating that sister cells undergo
apoptosis a few minutes apart (Figure 27). The similarity in apoptosis times could not be
correlated to the cell cycle (Figure 20), or the distance between cells (Figure 22-26).
Furthermore, not only are the apoptosis times between sister cells similar, but the fates of
sister cells are more similar that random (Figure 29). We also find that for related cells
that there is divergence in the times of apoptosis as cells become more unrelated (Figure
32). This divergence is also observed within single generations (Figure 34) and is limited
by blocking protein synthesis after division (Figure 36).
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Figure 37: Divergence of apoptosis times in sister cells in inhibited by puromycin.
(A) Experiment overview. We monitored the division of sister cells in a 3 hour
interval prior to puromycin (1 µg/ml) treatments. These newly divided cells were
followed under three different conditions which differed in the time that cells were
untreated with puromycin. All cells were then treated with staurosporine (STS) (1
µM) in the presence of puromycin (1 µg/ml). The duration of the puromycin
experiment is shorter than the cycloheximide (CHX) owing to greater cell death
prior to STS treatment, whereas cell death is negligible in the CHX experiment
prior to STS treatment. (B) Distributions of the difference in caspase activation of
sister cells under the three different puromycin treatments. The distribution
appears to flatten the longer the cells are not in the presence of puromycin. Data
binned in 30 minute intervals. Total number of cell pairs for each treatment is
between 32 and 37. (C) Average time of apoptosis under the three different
puromycin conditions. Error bars represent the 95% confidence interval of the
mean. (D) Population distribution of apoptosis times under the three different
puromycin conditions.
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Figure 37
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Chapter Four: Cytochrome c is released in a wave

Introduction
Mitochondria play a central role in apoptosis, integrating signals from members of
the Bcl-2 family (Danial and Korsmeyer, 2004), Opa and Parl (Pellegrini and Scorrano,
2007), and many other molecules. It has been proposed that mitochondria integrate these
signals, resulting in changes in membrane permeability to pro-apoptotic proteins (Ow et
al., 2008) and the fragmentation of mitochondria (ROUILLER, 1957; Zhuang et al.,
1998).

Once released from the mitochondria, cytochrome c interacts with Apaf-1,
resulting in the activation of caspases that in turn cleave several vital substrates, leading
to biochemical and morphological features characteristic of apoptosis (Li et al., 1997).
Membrane permeability to cytochrome c is considered a critical step in the progression of
apoptosis. Along with cytochrome c, Smac is also released into the cytosol (MunozPinedo et al., 2006). Once in the cytosol, Smac induces degradation of the inhibitor of
apoptosis proteins (IAPs), thereby facilitating caspase activation (Du et al., 2000;
Verhagen et al., 2000).

Around the same time, the mitochondrial intermembrane

becomes permeable to protons, causing loss of membrane potential (ΔΨm) (MunozPinedo et al., 2006), and the mitochondria are observed to fragment and undergo changes
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to their internal structure (Sun et al., 2007; Frezza et al., 2006). Furthermore, the precise
temporal order of these events is not completely resolved (Martinou and Youle, 2006;
Lakhani et al., 2006)

Although cytochrome c may be released in different cells at any time over a
period of several hours, its release within a single cell is completed within several
minutes (Goldstein et al., 2000). Thus, one of the major barriers to imaging the dynamics
of cytochrome c is that its onset is so variable that when imaging is done at high temporal
resolution, fluorescent tags are usually bleached before cytochrome c is initiated. This
has limited the ability to resolve whether cytochrome c and Smac are released at different
times or simultaneously (Munoz-Pinedo et al., 2006), or whether the increase in
permeability of the outer (Waterhouse et al., 2001) or inner (Gottlieb et al., 2003)
membrane occurs first.

Here, we show that cytochrome c release can be initiated at one, two, or multiple
points in a cell and then propagates across the cell. This behavior was observed for
apoptosis induced by a number of different drugs. Cytochrome c release took place
before Smac release and loss of ΔΨm, which also occurred in waves, though lagging in
time behind cytochrome c release. By analyzing individual mitochondria, we show that
mitochondrial fission occurs after cytochrome c release. Additionally, we examine the
dynamics of cytochrome c release from single mitochondria, showing that release occurs
in a single step from single mitochondria. Finally, we show that the wave of cytochrome
c release can be inhibited by thapsigargin (a blocker of the SERCA calcium pumps) but
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not with BAPTA-AM, which buffers cytosolic calcium levels.

These observations

indicate that the signal for mitochondria to release cytochrome c, and, in some cases, the
commitment to apoptosis does not take place simultaneously at all mitochondria, and
does not occur spontaneously within the cell.

Results
Wave of Cytochrome c – GFP Release in Single Cells

Initiation of apoptosis in a population of cultured cells is asynchronous and
distributed over several hours (Goldstein et al., 2000). Our observations in Chapter Three
suggest that we can approximately predict the time when a cell will undergo apoptosis
based on when its sister cell undergoes apoptosis (Figure 27). Furthermore, if we allow
HeLa cells to divide on a dish for more than 40 hours, we see a local synchrony of
apoptosis (Figure 14).

Therefore, to obtain high temporal resolution images of

cytochrome c GFP release, we plated HeLa cells and allowed them to divide for more
than 40 hours, then we treated cells with an apoptotic drug, imaged clusters HeLa cells
once every 2 minutes until one cell in a field released cytochrome c-GFP. At this point
the acquisition rate was increased to once every 5-10 seconds to capture the release of
cytochrome c-GFP in nearby cells that still had mitochondrial cytochrome c-GFP.
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An example of the dynamics of cytochrome c-GFP release in HeLa cells treated
with TNF-Related Apoptosis Inducing Ligand (TRAIL, 1 μg/mL) is shown in images
from a time-lapse experiment (Figure 38).

The release of cytochrome c-GFP was

initiated at one end of the cell (indicated by the arrow), and in successive frames a wave
of cytochrome c-GFP release swept across the cell. This continued for 90 seconds until
cytochrome c-GFP was no longer localized to mitochondria in the cell. This result is
consistent with a study published while our manuscript was in review, which also showed
a spatial release of cytochrome c (Lartigue et al., 2008).

To determine whether the loss of cytochrome c-GFP fluorescence was a result of
mitochondria moving out of the plane of focus, or a complete breakdown of
mitochondria, we monitored cytochrome c-GFP simultaneously with the mitochondria
marker mito-mCherry (Shaner et al., 2004; Rizzuto et al., 1995). During the loss of
localized cytochrome c-GFP fluorescence, there were no discernable changes in the mitomCherry fluorescence (Figure 38B). A wave of cytochrome c-GFP release was also
observed using confocal microscopy (Figure 39).
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Figure 38: Wave of cytochrome c GFP release in single cells. (A) Cytochrome cGFP release shows a spatial pattern of release initiating at the arrow and
progressing to the bottom of the cell and back to the lower portion of the nucleus.
(B) Mito-mCherry fluorescence does not change in this time.

Note that

mitochondrial fragmentation can be observed. (C) Overlay of the two images with
cytochrome c-GFP in green and mito-mCherry in red. Time in seconds with t = 0
indicating the time of first detectable release
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Figure 39: Wave of cytochrome c-GFP release in HeLa cells using confocal
microscopy. The top right shows a wave of release starting from the bottom and
progressing to the top of the cell. Time in minutes:seconds.

Quantification of Cytochrome c Release Waves

The release of cytochrome c-GFP from mitochondria was quantified using the
average intensity of GFP in regions of interest (ROIs) (Figure 40). Each ROI may
contain more than one mitochondria because it was not always possible to discern
individual mitochondrion in dense or out of focus regions of the cell. Therefore, the
contents of ROIs are referred to as mitochondrial clusters. Most of the mitochondria in a
cell were included within at least one ROI (Figure 40).
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Figure 40: A selected image before cytochrome c-GFP release demonstrating the
ROI coverage. The circles represent the regions of interest (ROIs) chosen for
analysis. The red circle is ROI in which the mitochondria released cytochrome cGFP first. Therefore, the time of cytochrome c -GFP release from this region
defined as t = 0 and all distance measurements are made relative to this region. The
lines represent distance measurements from the first ROI to four other ROIs. This
measurement is made for every ROI.

In an individual ROI over time, the average intensity of the cytochrome c-GFP
remained constant, then dropped to the local background level within 30 seconds (Figure
41A). In contrast, the mito-mCherry fluorescence remained at a constant level indicating
that movement of the mitochondria out of the ROI is not responsible for the drop in
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cytochrome c-GFP fluorescence (Figure 41A). In an individual cell, we observe that
different ROI release cytochrome c-GFP at different times (Figure 41B for the cell shown
in Figure 38).

To quantify the wave of release, we determined the first ROI in a cell to release
cytochrome c (Figure 40, red ROI). The time of cytochrome c release from an ROI was
defined as the point when the average intensity of the ROI began to decline irreversibly
(for example see Figure 41C). The time of release from the first ROI was set to t=0
seconds, and all time measurements were made relative to this ROI. We next calculated
the distances between the first ROI to release cytochrome c, and all other ROIs (see white
lines in Figure 40). Finally, to represent the wave, we plotted the distance from the first
ROI that released cytochrome c-GFP as a function of the time of ROI release (Figure
41D). A correlation plot of the distance of release as a function of the time of release for
the cell shown in Figure 40 revealed a linear relationship indicating the wave like nature
of cytochrome c release (Figure 41D).
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Figure 41: Quantification of cytochrome c-GFP release in a single cell. (A) The
normalized intensity for one ROI versus time for both cytochrome c-GFP (black +)
and mito-mCherry (gray ×). (B) Graph of cytochrome c-GFP loss from four
separate regions. (C) The normalized cytochrome c-GFP intensity vs. time for an
individual ROI. The black arrow indicates the time point selected as the release of
cytochrome c-GFP. This point is selected because the fluorescence intensity declines
irreversibly. The grey arrow indicates a point of decline which is not selected as the
time of release because of the subsequent recovery. (D) Plot showing the distance of
ROIs from the first ROI to release cytochrome c as a function of time of release (t=0
seconds for the first ROI to release cytochrome c). This plot corresponds to the cell
shown in Figure 40.
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Figure 41
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This analysis quantitatively shows that cell-wide release of cytochrome c-GFP
from mitochondria occurs as a propagating wave. To determine whether the wave of
cytochrome c release is specific to a single mode of apoptosis, we observed the dynamics
of cytochrome c release for cells treated with different agents that trigger apoptosis.
Similar results were observed when apoptosis was induced with the death receptor ligand
TRAIL (1 μg/mL) (Figure 38), protein kinase inhibitor staurosporine (STS, 2μM) (Figure
42) or the DNA damage inducing drug etoposide (ETO, 50µM) (data not shown). The
observation of the cytochrome c release wave in multiple modes of apoptosis indicates
that the wave is a general sub-cellular feature of apoptosis.

Patterns of cytochrome c release

In characterizing the release of cytochrome c, three different patterns of release
were observed (Figure 42). The first pattern is a wave initiated at a single point with the
release of cytochrome c propagating in one direction across the cell (Figure 42A,B). The
second pattern is two waves initiated at different points each propagating simultaneously
across the cell (Figure 42C,D). The majority of cells treated with STS or ETO, and
approximately half of cells treated with TRAIL (1 μg/mL) had a directional (one or two
point) pattern of release (Table 3). Waves initiating at one or two points were observed
in cells of oblong and round morphologies, indicating that cell shape did not induce a
significant bias to the mode of release (Figure 42A, 43).
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The third pattern of release of cytochrome c did not appear to be spatially
coordinated, though similar to the other patterns, the cell-wide release was complete
within minutes (Figure 42E,F). This could result from a wave that initiates at the top of
the cell, furthest from the cover slip, and propagates perpendicular to the imaging plane,
or from multiple spatially coordinated waves initiated at several points in the cell for
which we lack the spatial and temporal sensitivity to resolve, or simply indicate an
uncoordinated release.

We observed all three patterns of cytochrome c release with TRAIL, STS or ETO
induced apoptosis (Table 3), indicating that the spatial patterns of release are not
restricted to a single apoptotic paradigm. Furthermore, the wave of cytochrome c release
was also observed in murine melanoma B16F0 cells (data not shown), demonstrating that
the wave phenomena is not restricted to a single cell line. The release of cytochrome c in
a wave that occurs at one, two or multiple points in the cell indicates that the initial
trigger of the cytochrome c release wave can occur independently at multiple spatially
distinct points in the cells. This indicates that the biochemical precursor of cytochrome c
release is not a homogenous event within the cell, and instead is an accumulation of
activated factors at spatially localize points in the cell.
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Figure 42: Spatial patterns of cytochrome c release. (A) Release initiating from one
point in the cell. Release begins at the top of the cell and progresses down along the
cell. (B) Distance correlation plot of the cell in A shows a linear relation. (C)
Release initiating at two points in the cell. Release begins at the bottom of the cell,
and also at the top of the cell. (D) Quantification of the release indicates two distinct
linear relations consistent with two points of release. (E) Release that does not show
a spatial pattern. (F) Quantification of the release in E.
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Figure 42
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Table 3: Different patterns of cytochrome c release in response to different stimuli

Dynamics of Loss of ΔΨm and Cytochrome c Release

We next investigated the spatial and temporal relationships between events
thought to be coincident with, or mechanistically linked to, cytochrome c release
(Munoz-Pinedo et al., 2006). We first observed the dynamics of cytochrome c release
relative to the loss of mitochondrial inner membrane potential (ΔΨm) as monitored by
tetramethylrhodamine ethyl ester (TMRE). TMRE preferentially accumulates in actively
respiring mitochondria (Ehrenberg et al., 1988), and during apoptosis TMRE is lost from
the mitochondria at the same time as cytochrome c (Munoz-Pinedo et al., 2006).
Although TMRE loss is temporally proximal to the release of cytochrome c, it has been
observed that the pan-caspase inhibitor zVAD-fmk can delay the loss of TMRE relative
to cytochrome c GFP (Goldstein et al., 2000).

HeLa cells were transfected with cytochrome c-GFP and loaded with
TMRE. When these cells were treated with TRAIL (1 μg/mL), we observed that the
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release of cytochrome c-GFP from the mitochondria preceded the loss of ΔΨm (Figure
43A). Furthermore, the loss of ΔΨm followed the same spatial patterns as cytochrome c
release within the cell, though lagging in time (Figure 43A). This time delay was
quantified monitoring cytochrome c release and TMRE loss from a single ROI (Figure
43B).

To demonstrate the lag between TMRE loss and cytochrome c release for the cell
shown in Figure 43A, we plotted the correlation between distance from the first ROI to
release and the time of release for both cytochrome c release and of TMRE loss (Figure
43C). This shows that TMRE has a similar distance-time release plot that differs in that
it is shifted in the time axis. Furthermore, a correlation between the time of TMRE loss
and cytochrome c release in this cell shows that TMRE loss occurs after cytochrome c
release (Figure 43D). Finally, in 5 cells with a total of 150 ROI, we found that 146 of
150 ROI studied released cytochrome c-GFP before ΔΨm loss (Figure 43E). The average
time between cytochrome c release and ΔΨm loss in TRAIL treated cells was 90 ± 42
seconds (Figure 43E), demonstrating that loss of ΔΨm is not necessary for and does not
occur before cytochrome c release. Note that 2.7% (4 of 150) of ROI show that TMRE
loss occurs before cytochrome c release. This may result from an error in determining the
time at which fluorescence irreversibly decreases in an ROI. These results demonstrate
that cytochrome c is released from mitochondria before membrane potential is lost.
Unlike previous reports, these experiments were conducted in the absence of biochemical
inhibitors (Goldstein et al., 2000; Munoz-Pinedo et al., 2006).
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Figure 43: Mitochondrial release and loss of TMRE. HeLa cells treated with 2μM
of STS. (A) Release of cytochrome c proceeds from left to right around the nucleus
(top panel). TMRE loss occurs in approximately the same pattern but lagging in
time (lower panel). (B) The average intensity in a single ROI of cytochrome c-GFP
(black +) and TMRE (gray ×) versus time. (C) Correlation plot of distance of
cytochrome c-GFP release and TMRE loss as a function of time. (D) Correlation of
the time of cytochrome c-GFP release and the loss of potential for all regions. Gray
line indicates simultaneity.

(E) Histogram of the time difference between

cytochrome c release and TMRE loss for 150 ROI in 5 HeLa cells treated with
TRAIL (positive values indicate that cytochrome c is released before TMRE loss).
The average release difference is 90 ± 42 seconds.
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Figure 43
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Dynamics of Cytochrome c and Smac Release

Next we observed the release of Smac, a mitochondrial protein that is released to
the cytosol where it promotes apoptosis by inducing the degradation of the inhibitor of
apoptosis proteins (IAPs) (Du et al., 2000; Verhagen et al., 2000). Previous work
indicated that fluorescently-tagged Smac is simultaneously released with cytochrome cGFP (Munoz-Pinedo et al., 2006). By simultaneously monitoring Smac-mCherry and
cytochrome c-GFP at rates faster than previously published, we found that the release of
Smac-mCherry followed the same spatial pattern as cytochrome c-GFP, but lagging in
time (Figure 44).
We quantified the Smac delay using a similar analysis used to quantify the delay
in TMRE loss (Figure 45). First we found that cytochrome c release preceded Smac
release in a single ROI (Figure 45A). Next we plotted the distance of cytochrome c and
Smac release as a function of time for the cell in Figure 44, and found that Smac release
generally followed cytochrome c release (Figure 45B). This was also demonstrated by a
correlation plot of the time of cytochrome c and Smac release (Figure 45C). Finally, by
monitoring 312 ROI in 6 different cells, we found that Smac release followed cytochrome
c-GFP release in 301 of 312 ROI with an average delay of 42 ± 29 seconds (Figure 45D).
A few ROI (11 of 312; 3.5%) show that Smac is released before cytochrome c, which
may result from an error of determining the time at which fluorescence irreversibly
decreases in an ROI.
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Figure 44: Widefield time lapse images of cytochrome c-GFP release and SmacmCherry release in the same cell. HeLa cells were treated with 2 μM of STS.
Cytochrome c release starts at the top of the cells and propagates to the bottom of
the cell. Smac release lags in time behind cytochrome c release, but follows a similar
pattern.
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Figure 45: Quantification of cytochrome c-GFP release and Smac-mCherry release
in the same cell. HeLa cells were treated with 2 μM of STS. (A) The average
intensity in a single ROI of cytochrome c-GFP (black +) and Smac-mCherry (gray
×) versus time. (B) Plot of cytochrome c-GFP release and Smac-mCherry release as
a function of time. (C) Correlation of the time of cytochrome c-GFP release and the
time of Smac-mCherry release for all regions. Dotted line indicates simultaneity.
(D) Histogram of the time difference between cytochrome c release and Smac
release for 312 ROI in 6 HeLa cells treated with TRAIL(positive values indicate that
cytochrome c is released before Smac). The average release difference is 42 ± 28
seconds.
120

We observe a delay between loss of ΔΨm and Smac release, relative to cytochrome
c release, and all three events occur in a similar spatial pattern. Although the release is
distinct, the spatial and temporal similarity suggests that there is one underlying
mechanism governing cytochrome c and Smac release and ΔΨm loss from individual
mitochondria. The delay observed between the Smac and cytochrome c waves could be a
result of pores that preferentially release cytochrome c and then Smac. However, a delay
could also be caused if Smac is oligomerized with itself or another protein (Du et al.,
2000). The time between cytochrome c-GFP loss and loss of membrane potential could
result from a delay associated with the breakdown of the electron transport chain,
although there is evidence that loss of potential requires caspase activation (Goldstein et
al., 2000; Goldstein et al., 2005).

Mitochondrial Fission
We next investigated the temporal relationship between cytochrome c release and
mitochondrial fission using the mitochondrial marker mito-mCherry (Figure 46).
Mitochondrial fission proteins have been implicated in cytochrome c release during
apoptosis (Suen et al., 2008; Frank et al., 2001; Karbowski et al., 2002). Furthermore,
mitochondrial fragmentation is reported to occur simultaneously with, or within minutes
of cytochrome c release (Karbowski et al., 2002).
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To resolve the timing of these events, we first monitored individual mitochondria
located primarily at the periphery of cells where there is lower spatial density of
mitochondria. In HeLa cells treated with TRAIL (1μg/mL), we observed that
cytochrome c-GFP was released prior to mitochondrial fission (24 mitochondria in 9
cells). A representative image of cytochrome c release and mitochondrial fission from a
single mitochondria is shown in Figure 47.

Alterations in the mitochondrial morphology were observed in the time between
cytochrome c release and prior to mitochondrial fission. The morphological alterations
were characterized by the formation of multiple fluorescent aggregates with thinner
intermediate connections (Figure 48A). These fluorescent aggregates and intermediate
connections were quantified with a line scan of mitochondria (Figure 48B). The size,
distribution, and duration of these aggregates varied between mitochondria (data not
shown). In total we observed similar intermediate morphologies for 15 of 23
mitochondria observed.

The observation of alterations of mitochondrial morphology indicates that
structural changes may precede complete mitochondria fission. These changes could be
due to the restriction of mitochondria by proteins such as Fis1, and Drp1 (Karbowski et
al., 2002) the formation of pores at the restriction sites (Kuwana et al., 2002) or the
swelling of the inner membrane space (Sun et al., 2007).
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Figure 46: Mitochondrial morphology before, during, and after cytochrome c-GFP
release. Mito-mCherry showing mitochondrial morphology in a HeLa cell treated
with TRAIL. Cytochrome c release began at t =0. Scale bar = 5μm
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Figure 47: Images of a single mitochondria undergoing cytochrome c release and
mitochondrial fission. HeLa cells were transfected with (A) mito-mCherry and (B)
cytochrome c-GFP and treated with 2μM of TRAIL. In white boxes are the frames
where cytochrome c release is occurring. Images are taken every 5 seconds.
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Figure 48: Mitochondrial fission and release of cytochrome c from single
mitochondria. HeLa cells transfected with cytochrome c-GFP and mito-mCherry,
and treated with TRAIL. (A) Images of cytochrome c release and mitochondrial
fission. Cytochrome c release begins at time t = 0. Arrows indicate sites of fission;
arrowheads indicate sites of morphological changes. (B) Line scans of mitochondria
from A with mito-mCherry in black and cytochrome c-GFP in gray. Arrows
indicate corresponding positions of arrows on image.
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Release of Cytochrome c from individual mitochondria

We imaged cytochrome c release from individual mitochondria to determine
whether release occurred in a single step, as a two step process (Ott et al., 2002), or
moved like a wave across each mitochondria. It has been shown that cytochrome c is
localized to intra-cristae regions of the mitochondria with limited access to the
intermembrane space (Scorrano et al., 2002). The release of cytochrome c from
individual mitochondria is difficult to monitor because of the variable onset of apoptosis
within single cells, and the rapid release of cytochrome c from individual mitochondria.
Furthermore, the density of mitochondria makes it very difficult to discern individual
mitochondria in wide field or confocal microscopy. To overcome the timing problem we
imaged several single cells once every minute, and once cytochrome c was released in a
single cell, we monitored adjacent cells once every ten seconds. These cells were then
imaged every 10 seconds, until cytochrome c release was detected in single mitochondria
and then we acquired images once every 400 ms.

For improved spatial resolution of individual mitochondria we imaged with total
internal reflection microscopy (Axelrod, 1989), which illuminates only the very bottom
of the cell within 200nm of the coverslip.

This allows imaging of a subset of

mitochondria with limited out of focus background fluorescence. Under these conditions
we could monitor the cytochrome c-GFP throughout the length of the mitochondria
(Figure 49A). Decrease in cytochrome c-GFP fluorescence appeared to initiate at the
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same time through the entire mitochondria.

A quantification of the fluorescence

demonstrated that neither the time when cytochrome c release initiated nor the time
course of release, were functions of the position along the mitochondria (Figure 49B).

Figure 49: (A) Release of cytochrome c-GFP from individual mitochondria as
revealed by TIR microscopy. Cytochrome c release begins at time t = 0. (B)
Quantification of cytochrome c release from different regions of the single
mitochondria in A. Release appears to initiate at the same time throughout the
mitochondria. Scale bars represent 5 μm.
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Inhibition of cytochrome c Release Wave

The spatial waves of release illustrate that cytochrome c is not simultaneously
released from all mitochondria in a single cell. Potential mechanisms to explain the
spatial coordination of cytochrome c release include local activation of a precursor to
release and a feed-forward loop that amplifies the initial loss of mitochondrial proteins.
There is evidence suggesting a link between cytochrome c release, inositol 1,4,5
triphosphate receptor (IP3R), and ER calcium stores (Boehning et al., 2005; Boehning et
al., 2003). This potential role for calcium is consistent with the ability of the Bcl-2
family to modulate cellular calcium levels (Foyouzi-Youssefi et al., 2000; Palmer et al.,
2004; Scorrano et al., 2003), as well as the observation of calcium waves in apoptotic
cells (Pacher and Hajnoczky, 2001; Szabadkai et al., 2004).

We tested the effects of reducing the cytosolic calcium with BAPTA-AM and
depleting ER calcium with thapsigargin (Palmer et al., 2004) on the spatial and temporal
characteristics of cytochrome c release. HeLa cells expressing cytochrome c-GFP were
treated with TRAIL (1 μg/mL) to induce apoptosis in the presence of extracellular EGTA
(1.2mM). Once one cell in the field released cytochrome c, BAPTA-AM (1mM) was
added to the bath. Calcium levels were stably reduced within 5 minutes of BAPTA-AM
addition to media (data not shown). The time for 95% of the ROIs in a cell to release
cytochrome c-GFP increased slightly from 112 ± 31 seconds for cells treated with TRAIL
and EGTA, to 153 ± 49 seconds (p=0.025) for cells treated with BAPTA-AM (Figure
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50A). There was a negligible change in the fraction of cells with a directional release
(from 0.50 to 0.57, Figure 50B). The effects of thapsigargin (5μM), were larger in
magnitude and significance. The time for a cell to release cytochrome c increased over
four fold (112 ± 31 sec to 511 ± 245 sec, p=2.2*10-6, Figure 50A) in cells that were
treated with thapsigargin.

Additionally, thapsigargin reduced the fraction of cells

showing directional release patterns from 0.5 to 0.053) (Fig. 48B). Thus thapsigargin
both disrupted the spatial wave of cytochrome c release and increased the duration of
release by more than 6 minutes.

Summary
In this chapter, we described the spatial coordination of cytochrome c release,
Smac release, and loss of ΔΨm. We observed that cytochrome c release occurs in a wave
that can initiate from one point in the cell, two points in the cell, or randomly through the
cell (Figure 42). The spatial wave of release could be observed with staurosporine,
TRAIL and etoposide indicating that this is a phenomena that occurs in different modes
of apoptosis. Smac release and loss of ΔΨm lagged in time behind cytochrome c release.
However, in single cells, Smac release, and loss of ΔΨm exhibited the same spatial
pattern as cytochrome c release (Figures 43, 45). Finally, we observed that mitochondria
underwent fission after cytochrome c release (Figure 48). The wave of cytochrome c
release was inhibited by treatment with thapsigargin (Figure 50).
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Figure 50: Thapsigargin, but not BAPTA, disrupts the wave of cytochrome c
release. HeLa cells in 1.2 mM EGTA undergoing TRAIL-mediated apoptosis were
treated with 1 mM BAPTA-AM (BAPTA) or 5 μM thapsigargin. (A) Duration of
cytochrome c release (95% of all ROIs released). Thapsigargin increased the
duration of release (p = 2.2 × 10−6), whereas BAPTA did not (p = 0.025).
Thapsigargin, but not BAPTA, disrupts the wave of cytochrome c release. HeLa
cells in 1.2 mM EGTA undergoing TRAIL-mediated apoptosis were treated with 1
mM BAPTA-AM (BAPTA) or 5 μM thapsigargin. (B) Bar graph showing the
fraction of cells with directional release. Numbers indicate (directionally releasing
cells)/(total cells).
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Figure 50
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Figure 51:

Chapter Five: Conclusions and Future Directions

In this thesis we described the development of two new reporters for monitoring
caspase activation in single cells (Chapter Two). This reporter was expressed in a
population of cells where we observed a similarity in the time of caspase activation of
related cells relative to the overall population (Chapter Three).

This similarity in

apoptosis timing was used to monitor mitochondrial apoptotic events in single cells with
high temporal resolution where we observed the spatial pattern of cytochrome c release
(Chapter Four). Below we discuss the implications of this work, and potential future
directions.

Caspase Reporter
The designed reporters (erDEVD and pmDEVD) relocalize from one organelle to
another after caspase activation. The pmDEVD reporter consists of a single fluorophore
which is relocalized from the plasma membrane to the cytosol after the activation of the
caspases, and the erDEVD reporter relocalizes from the ER to the nucleus after caspase
activation. On the basis of signal strength and kinetic properties the pmDEVD reporter is
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comparable to or better than other genetically encoded caspase reporters (FRET,
pCaspase-3, and erDEVD). Importantly, the reporter uses only a single fluorophore
which enables simultaneous use of the pmDEVD reporter along with probes for other
processes. Here, we were able to simultaneously monitor other events such as the cell
cycle and cytochrome c release.

Finally we determined that the expression of the

pmDEVD reporter does not have an effect on the kinetics of downstream steps of
apoptosis such as TUNEL staining.

The relocalization reporters can be modified to other proteases such as granzymes
or initiator caspases by modifying the cleavage domain (Thornberry et al., 1997). This is
potentially difficult owing to overlapping substrate specificities and low levels proteolytic
activity in weaker proteases (such as the initiator caspases). To improve the reporter
signal for detection of weaker proteases future modifications might include cotranslational targeting to the plasma membrane, and the addition of a nuclear localization
signal. This would aggregate the cleaved fluorophores in the nucleus which would be
more easily detectable than if the reporter is localized to just the cytoplasm. Furthermore,
to aid in the detection of weaker caspases, it may be useful to fuse protein-protein
interaction domains such as CARD (for the detection of caspase-9) or DED domains (for
the detection of caspase-8) to these reporters to help localize these weaker caspases to the
reporter.
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Sister Cell Apoptosis
We observe that sister cells undergo activation of caspase-3/7 at similar times
relative to the population. This similarity could not be correlated to the position of cells
in the cell cycle, nor to the distance between cells. By investigating the similarity of
apoptosis susceptibility over subsequent generations, we observe a divergence in the
times of apoptosis as cells are more unrelated. A divergence in apoptosis susceptibility is
also observed within single generations and is limited by blocking protein synthesis after
division. These results suggest that the signal transduction in response to apoptotic
stimuli reflects the internal state of the cell and therefore is deterministic.

Overview of variability
A precise apoptotic response might be expected given its importance in executing
developmental programs or ensuring destruction of aberrant cells. However, the time
when a cell irreversibly commits to apoptosis can vary from 1 hour to over 20 hours
depending on the type and strength of the apoptotic stimulus (Goldstein et al., 2000).
Variability of cell fate decisions in clonally identical populations is also observed in
phage lambda infection (Arkin et al., 1998), bacterial chemotaxis (Spudich and Koshland,
Jr., 1976), cell differentiation (Abkowitz et al., 1996; Enver et al., 1998), and HIV-1 Tat
transactivation (Weinberger et al., 2005). While phenotypic variability can be beneficial
in certain scenarios such as in stress responses or environmental fluctuations (Kussell and
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Leibler, 2005) it also imposes limits on the precise control of cellular fate. In the context
of apoptosis, variability can be resolved into two components: a stochasticity in how
biochemical signals are transduced after drug treatment, or a population-level
heterogeneity of cellular factors (Kaern et al., 2005). It is difficult to experimentally
resolve contributions of the different components owing to an inability to precisely
replicate the biological conditions of a single cell.

Entry into apoptosis is similar for cells in proximity
When studying the times of apoptosis in a population, we noticed that the times
for neighboring cells to enter apoptosis were highly correlated relative to more distant
cells (Figure 14). One potential explanation for such a correlation would be secreted
factors, which have been demonstrated to play a significant role in apoptosis. However,
three independent tests demonstrated that there was no correlation between when
caspases were activated and the physical distances between unrelated cells (Figures 2326). Thus, the secreted factors may either be acting only on the secreting cell itself or on
the culture as a whole, but not affecting the local microenvironment. Therefore while
secreted factors play a role in the apoptosis decision, they may not be the underlying
source of cell-cell variability.
Depending on the method of inducing apoptosis, previous work reported a
correlation between apoptosis and the cell cycle (Stacey et al., 2000), or a lack of
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correlation (Hueber et al., 1998; Cohen et al., 2008). Since recently divided cells both
tend to be near each other and tend to be synchronized in the cell cycle, this might also
account for the “local synchronization”.

This was tested with two different assays:

Apoptosis was induced in a cell cycle synchronized population (double thymidine block)
(Figure 16) or apoptosis was induced in an asynchronous population where the cell cycle
phase was determined using a live cell reporter (Figure 20). In both assays there was no
detectable correlation between cell cycle and apoptosis. .

Entry into apoptosis is similar for related cells
When neighboring cells were categorized into sister cells, cousins or unrelated
cells, sister cells showed the greatest similarity for the time of entering apoptosis (Figure
26).

Apoptosis times of sister cells are most similar right after division, and this

similarity decreases over time (Figure 34). When weaker apoptotic insults were used we
found that not only was the timing of apoptosis correlated for sister cells, but also the
probably of apoptosing. Thus, fates were linked in sister cells (Figure 29) Although
phenotypic similarities between sister cells have been shown with respect to the duration
of the cell cycle (Dover and Potten, 1988; Nasmyth et al., 1979), and in some cases cell
migration (Albrecht-Buehler, 1977) to our knowledge, this has not been shown with
respect to apoptosis nor for any cellular phenotype in response to an exogenous trigger.
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Determinism in Apoptosis Signal Transduction
The similarity of apoptosis times and the apoptotic fate of sister cells suggest that
the time of apoptosis, and the fate of a single cell in response to an apoptosis stimulus is
predictable. This predictability of apoptotic signal transduction suggests that cells which
undergo apoptosis at a later time relative to the population may have molecular
compositions that make the cell less susceptible to apoptosis, and do not result from
stochastic events in apoptosis signal transduction.
While the difference in apoptosis time between sister cells is much smaller than
expected if the entry to apoptosis was completely stochastic, the apoptosis times of sister
cells was not identical (Figure 28). One explanation is that the biochemical signal
transduction in response to apoptotic stimuli may have some stochastic steps.
Alternatively, the dilution of factors during division may not be symmetric, or the
molecular composition of daughter cells may diverge after division.

The latter

explanation is consistent results showing that as cells spend more time apart, their
difference in caspase activation increases (Figure 34).

Divergence of Apoptotic Susceptibility
Sister and cousin cells underwent apoptosis at similar times but as cells became
more distantly related, the difference in their times of apoptosis increased (Figure 32, 34).
This divergence of apoptotic fate was observed to occur over a few generations,
137

suggesting that the molecular composition of the cell which predisposes cells to apoptosis
is transient.

A similar influence of lineage on phenotypic behavior is seen in the

switching times of S. cerevisiae that were engineered to switch between galactose
metabolizing and non-metabolizing states (Kaufmann et al., 2007).
Our results are reminiscent of prior results on the variability of gene expression in
a lineage of mammalian cells (Sigal et al., 2006b). Sigal et al. calculated the kinetics and
genealogical time over when the gene expression levels in a cell lineage reach the
different expression levels found in the population.

Our results build upon the

demonstration of divergence in gene expression, to show a divergence of phenotype
within a lineage. Strikingly, our half-time of divergence of the apoptosis response is on a
similar scale as divergence in the gene expression study, thus suggesting that the
divergence of gene expression levels in mammalian cells has a phenotypic consequence
(Newman and Weissman, 2006).

Divergence from New Protein Synthesis
The similarity in apoptosis time between sister cells is observed for three distinct
apoptosis inducing drugs (STS, TNFα, and ETO) and in different cell lines and in nonimmortalized MEFs.

This indicates that the mechanism generating diversity and

persistence of the apoptotic state could be a few proteins common to the different
apoptosis drugs, or could be a global mechanism affecting all proteins of which variation
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in apoptosis signaling is only one consequence. The intragenerational variation in the
apoptosis susceptibility could result from a gradual change in the cellular components
which could reflect increasing differences in gene expression. Notably, Sigal et al.
reported that variation in gene expression was found for distinct classes of proteins (Sigal
et al., 2006b).
The divergence of apoptosis times of sister cells was inhibited by blocking protein
synthesis after division, suggesting that variation in apoptosis is in part a result of a
variation in protein synthesis just after division. Other molecular changes may contribute
including the degradation of proteins, the post-translational modifications of proteins, and
the localization of proteins. We propose that if the molecular composition of the cell, and
the underlying biochemical network used to process apoptotic triggers is similar between
sister cells at the time of treatment, the apoptosis times will be similar. However as the
molecular composition of cells start to drift apart, so does the apoptotic response. Thus,
while the biochemical reactions triggered by an apoptotic signal may be deterministic, the
reactions that determine the molecular composition of the cell prior to the addition of an
apoptosis drug may not be.
An understanding of the mechanisms of apoptosis will be aided by the
development of techniques to monitor the expression and activity of different apoptotic
proteins in single cells. Such reporters can be used along with the developed pmDEVD
reporter, which uses only a single fluorophore, to correlate the times of reporter
activation to time of caspase activation. This will help elucidate both the timing of events
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and the determination of whether the variability between cells is the result of a specific
apoptotic stage or of small variations in multiple stages.
Broadly, these results highlight the benefits of single cell assays in addition to
monitoring population phenotypes. In a population, there is a substantial distribution in
the onset of apoptosis. This is not just a stochastic transduction of an apoptotic signal,
but a difference resulting from population heterogeneity. The determinism of signal
transduction in single cells should enable the observation of processes that are too rapid
to be continuously imaged such as cytochrome c or Smac release (Chapter Four). This
can be potentially done by waiting for a cell to undergo apoptosis at low imaging
frequency, then imaging its sister cell, or related cells at a higher frequency.

The

symmetry of division reproduces underlying biochemical networks that cells use to
respond to external triggers. Exploiting this symmetry by comparing responses in sister
cells enables an understanding of the reproducibility of the response of these signaling
networks, and how biochemical signals are transduced. It remains to be seen whether this
similarity extends to other phenotypes, and whether it extends to phenotypes in vivo.

Cytochrome c Release
Rapid imaging during apoptosis revealed a spatial coordination of cytochrome c
release, Smac release, and loss of ΔΨm. Three spatial patterns of cytochrome c release
were observed: waves initiating at one or two points in the cell, and an apparent random
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release. The release of Smac and loss of ΔΨm exhibited a spatial pattern similar to that of
cytochrome c release. Only one temporal pattern was observed: first, the mitochondria
lost cytochrome c and then they lost Smac, which was followed by the loss of
mitochondrial energetics, as assayed by the ΔΨm. The mitochondria underwent fission
after cytochrome c release. The wave of cytochrome c release was inhibited by treatment
with thapsigargin.

Waves of cytochrome c release

The cell-wide release of cytochrome c-GFP was previously observed to occur in
an all-or-none manner (Goldstein et al., 2000) and, more recently, in a wave propagating
across single or fused cells (Lartigue et al., 2008). The existence of a wave suggests that
the upstream trigger of cytochrome c release is spatially localized. Though the identity of
the trigger is unknown, possible triggers include the members of the Bcl-2 family (Youle
and Strasser, 2008) and the initiator caspases. Here, we observed waves initiating not
only at a single point in a cell, but also at two spatially distinct points in a cell (Figure
42). This indicates that although the trigger initiating the wave of cytochrome c release is
spatially localized, it can occur in multiple locations independently within a single cell.
Therefore, although there may be multiple points for the initiating pro-apoptotic trigger
within the cell, cytochrome c-GFP release is initiated only when the concentration or
activity of the precursor crosses a threshold.
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Other mitochondrial events

The similar spatial pattern observed within each cell between the release of
cytochrome c-GFP and Smac-mCherry and the subsequent loss of ΔΨm suggests that
although these events are not coincident, they are part of the same process. The temporal
lag between the release of cytochrome c-GFP and Smac-mCherry could indicate different
submitochondrial localizations of the proteins, different binding interactions that delay
release of Smac-mCherry, or a pore that is selective for cytochrome c-GFP.

The temporal lag that was observed between the release of cytochrome c-GFP and
the loss of TMRE shows that ΔΨm and thus the integrity of the inner membrane
permeability and mitochondrial energetics are maintained during cytochrome c release.
Thus, loss of mitochondria energetics is unlikely to be a causal trigger for the loss of the
proteins cytochrome c and Smac. This is consistent with a model in which apoptosis is
initiated in the cytoplasm, permeabilizing the outer membrane, followed by inner
membrane permeabilization and then loss of potential (Basanez et al., 1999). However, it
is important to keep in mind that our experiments were done with fusion proteins, which
may have different localizations than the endogenous proteins, resulting in different
release dynamics.
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Mitochondrial morphological changes

It has been proposed that the release of cytochrome c may be a consequence of
fission of the mitochondria and the subsequent release of mitochondrial contents
(Martinou and Youle, 2006). Here, we define mitochondrial fission as the point at which
a break occurs in the mitochondria as observed by microscopy. The observation that
cytochrome c-GFP release precedes mitochondrial fission (Figure 47) indicates that
fission is not necessary for the release of cytochrome c from individual mitochondria. It
is unlikely that there are significant tears in the mitochondrial membrane that we are not
detecting due to limited optical resolution, since the mitochondria still maintain their
membrane potential. However, it is possible that the tears are restricted to only the outer
membrane. Alternatively, there may be local fissions, but the two halves of the
mitochondria do not move apart until after the release of cytochrome c and Smac. This
observation is consistent with evidence that multiple components of the mitochondrial
fission machinery, such as Drp1, are involved in promoting the release of cytochrome c.
It is also possible that these proteins are multifunctional and use different mechanisms in
their roles to reshape mitochondria and to promote the release of proteins from
mitochondria (Cassidy-Stone et al., 2008).

When we imaged single mitochondria expressing mito-mCherry, we observed a
distinct mitochondrial morphology characterized by multiple fluorescent aggregates with
thinner intermediate connections. This could result from the recruitment of proteins such
as Bax, Drp1, or Fis1, which cause restrictions at localized mitochondrial sites
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(Karbowski et al., 2002), or from alterations of internal mitochondria structures (Sun et
al., 2007). This recruitment or alteration could be a precursor to mitochondrial fission.

Cytochrome c release from a single mitochondria

To gain insight into the release of cytochrome c, we imaged the release from
individual mitochondria with subsecond resolution. This revealed that cytochrome c
release from individual mitochondria occurs in a single step. This imaging technique will
be beneficial for investigating events associated with cytochrome c release that are too
fast to image by laser scanning confocal microscopy, and with a greater z-spatial
resolution than that provided by wide-field or confocal microscopy.

Wave mechanism

One possible mechanism for the wave of cytochrome c release is a factor that
diffuses across the cell, triggering the mitochondria to release cytochrome c.
Alternatively, a wave could result from an initial release of cytochrome c, followed by a
feed-forward loop that amplifies the initial release. A role for ER calcium in the feedforward mechanism is supported by our experiments in cells treated with thapsigargin,
which showed a prolonged duration and lack of spatial organization of cytochrome c
release. This is consistent with previous work showing a link between cytochrome c and
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calcium release from the ER, which in turn triggers cytochrome c release from the
remaining mitochondria (Boehning et al., 2003; Boehning et al., 2005). However, loading
the cytosol with 1 mM of BAPTA did not prolong or disrupt the spatial organization of
the wave. This suggests that calcium signaling does not occur through the cytoplasm, and
instead occurs through close contacts between the ER and the mitochondria (Rizzuto et
al., 1998). Alternately, thapsigargin could have an off-target effect, perhaps by altering
mitochondrial calcium levels, which has been observed with higher concentrations of
thapsigargin (Vercesi et al., 1993). Ultimately, a biochemical dissection of the
mechanisms of the wave will be required.

Future Directions

Cytochrome c Release
We observed that cytochrome c was released in a wave in response to STS,
TRAIL and ETO, which trigger apoptosis through stress, death receptors and DNA
damage pathways respectively. To gain insight into the origin points of the release wave,
we could also use other methods to induce apoptosis that stimulate direct components of
apoptosis pathways. One possibility would be to use Bcl-2 mimetics or inhibitors to
determine whether these affect the wave or the number of starting points of the wave.
For example, we could use the Bcl-2 inhibitor ABT-737 which is proposed to inhibit the
anti-apoptotic activity of Bcl-2, Bcl-XL and Bcl-W and induce apoptosis (Oltersdorf et
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al., 2005; Cragg et al., 2009), or we could use obatoclax which is proposed to inhibit the
interaction between Mcl-1 and Bak (Nguyen et al., 2007), or more generally, we could
express select BH3 peptides which induce release of mitochondrial proteins by directly
acting on Bax or Bak (Letai et al., 2002; Walensky et al., 2006). If there is no spatial
localization of these molecules or peptides in the cell, then if the spatial pattern of release
in response to STS or TRAIL is caused by a gradient of Bax or Bak activation in the cell,
the spatial pattern may not be present in response to ABT-737, obatoclax, or the BH3
peptides.
We were able to demonstrate that the application of thapsigargin to cells prior to
inducing apoptosis was able to inhibit the wave of release, and slow down the overall
release in the cell. However, thapsigargin is known to have off target effects (Vercesi et
al., 1993), and without identifying specific molecules, or without inhibiting the wave
using another inhibitor, it is not possible to rule out this effect. Some of the potential
molecules involved in a feed-forward loop include calcium signaling molecules or
molecules that are closely associated with both the mitochondria and the endoplasmic
reticulum. For example, one of the possible interactions that was not investigated in
Chapter Four is the interaction of cytochrome c with the IP3R (Boehning et al., 2003;
Boehning et al., 2005). It has been demonstrated that cytochrome c interacts with amino
acids 2621-2636 of type I IP3R thereby stimulating calcium release from the ER, which is
proposed to induce further cytochrome c release (Boehning et al., 2003). A peptide
comprising amino acids 2621-2636 of type I IP3R has been shown to bind to cytochrome
c, and inhibit the interaction between cytochrome c and endogenous IP3R (Boehning et
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al., 2005). It would be interesting to determine if this peptide could inhibit the wave of
cytochrome c release.
A more general and less directed approach to identify molecules involved in wave
propagation would involve performing a screen using a library of shRNA to determine
which shRNAs would inhibit or modify the wave (Hitomi et al., 2008). This would
require setting up a fluorescent assay to monitor the wave in a high-throughput way that
would enable a screen in a reasonable time. Our approach to image the wave has been to
wait for one cell to die, then to image rapidly. This was done with a 60x objective to get
the maximal resolution to characterize the phenomenon.

However, this level of

resolution or prediction of apoptosis may not be necessary to observe the wave. At 10x
resolution, it is possible to observe cytochrome c at different areas in the cell. Thus,
while it may not be possible to resolve the detail of the waves, or all waves in all cells, it
may still be possible to see fractional release.
The low-powered objective would enable the imaging of more cells. In imaging
many cells, and by imaging at a time when most cells in the population are releasing
cytochrome c (i.e. the maximum of the Gaussian), it may be possible to reproducibly
observe a small percentage of cells undergoing spatial patterns of cytochrome c release.
This would speed up the experimental time and reduce the effort for monitoring a wave
of release and may enable a shRNA screen.
While we were able to monitor the release of cytochrome c in single cells, it is not
clear if this is a process that occurs in vivo, or whether it is an artifact of cultured cells.
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One way to test this would be to express a cytochrome c-GFP fusion in mice, and image
cytochrome c GFP release in tissues undergoing apoptosis. Alternatively we could image
cytochrome c homologs in other organisms such as C. elegans (ced-4), or D.
Melanogaster (though it is not clear whether drosophila cytochrome c is released during
apoptosis). In all of these instances, it would be interesting to determine whether the
wave occurs at the same speed, and whether there is randomly occurring release.

Sister Cell Apoptosis
While we find that sister cells undergo apoptosis at similar times, these times are
not exactly the same. Our data shows that while blocking protein synthesis can reduce
the dissimilarity, it does not completely eliminate the difference. Another source of
dissimilarity is cell-cell variation caused by variation in protein degradation. Thus we
could inhibit protein degradation using mg132 at various times after cell division and
determine whether this has an effect on the divergence of sister cell apoptosis.
To isolate molecules responsible for the divergence, we could perform a shRNA
screen. Again, this would require fully automating tracking the lineage of cells, the onset
of apoptosis, and the subsequent analysis. It would then be possible to monitor which
shRNA alters the similarity or the divergence of apoptosis times. It is possible that this
will not only result in the identification of genes involved in apoptosis but possibly
molecules involved in gene expression regulation and genomic stability.
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Finally, to gain insight into what predisposes some cells to undergo
apoptosis early relative to the population, we could isolate cells based on when they
undergo apoptosis. One possibility is to perform this isolation using flow cytometry
where we sort cells twice: first keeping cells that are alive, then sorting shortly afterwards
to select cells that have undergone caspase activation in the time between the sorts. This
would select for cells that have undergone apoptosis in this short interval. By assaying
the gene expression of these cells it might be possible to identify specific molecules that
are up or down regulated in early or late dying cells. This analysis presumes that there
are subsets of molecules that are responsible, and that not all molecules are changing.
For example, different cells may have different molecular reasons for their susceptibility,
which could confound this experimental approach.
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Chapter Six: Experimental Procedures
General Methods
Cell Culture
HeLa, NIH3T3, MEF, B16F0, and HT1080 cells were maintained at 5% CO2 in
DMEM (Gibco) containing 10% FBS (Gibco).

Cells were maintained on 10 cm

polystyrene dishes (Corning), and were passaged approximately every two days. For
imaging, cells were plated on Mattek glass bottom dishes. Two different sized dishes
were used depending on the nature of the experiment (10mm and 20mm). Long term
multiwell imaging experiments were performed in 24 well dishes (BD Bioscience).

Induction of Apoptosis
Apoptosis was induced with sFasL (BioVision, Mountain View, CA), TRAIL
(BioVision), staurosporine (Sigma, St. Louis, MO), etoposide (BioVision), TNFα
(BioVision), cycloheximide (Sigma). Drugs were mixed with media well prior to the
addition of media to cells
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Transfection
Cells were transiently transfected with Lipofectamine 2000 (Invitrogen), or with
Fugene (Roche). Fluorescence expression started to occur as early as 8 hours after
Transfection.

Generation of Stable Cell Lines
Stable cell lines were generated using lentiviral infection. Briefly cDNA was
cloned into a pLNCX vector (Clontech). HEK293T Phoenix cells – which express viral
coat proteins - were transfected with the pLNCX modified vector, thus producing viral
particles. Supernatant containing viral particles were collected diluted 1:2 in DMEM and
added to the target cells. Cells were allowed to grow over several days. Infection
efficiency varied from ~ 5% to 20 %.

Cells were selected using flow cytometry

(Rockefeller FACS Center).

Fluorophores
We used the fluorophores mCerulean, mCitrine, mCherry for the non-FRET
constructs. CyPet and yPet (optimized from CFP and YFP respectively) were used in the
FRET construct. mCherry and mCitrine were obtained from Roger Tsien (Shaner et al.,
2004). CyPet and yPet obtained from Patrick Daugherty (Nguyen and Daugherty, 2005).
mCerulean was obtained from David Piston (Rizzo et al., 2004).
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Fluorescence Microscopy
For widefield microscopy, we used an Olympus IX-81 microscope with Xenon
lamp illumination source, and an Orca ER CCD camera (Hamamatsu). This microscope
had an automated stage to enable the collection of data from multiple fields (Prior
Scientific). The images were recorded using exposure times of 100-300ms. Image
acquisition was performed using Metamorph software (Molecular Devices, Sunnyvale,
CA). . The microscope was enclosed by a plexiglass chamber made by the Rockefeller
High Energy Machine Shop. We used a 60x 1.2NA water immersion objective, a 40x 0.8
NA air objective and a 10X 0.6 NA air objective.
Filter settings were organized to enable the detection of multiple fluorophores in
the same cell. All filters were purchased from Chroma. The filters are listed below:
Table 5: Olympus IX81 Filters
Fluorophore

Excitation Filter

Emission Filter

Dichroic

DAPI

360/40

400/LP

DAPI 61002
Polychroic

mCerulean

ET 430/24

ET470/24

CFP/YFP/mCherry
89006 polychroic

GFP

HQ 470/40

HQ 520/50

495 long pass

mCitrine

ET 500/20

ET 535/30

CFP/YFP/mCherry
89006 polychroic

mCherry/TMRE

ET 577/25

ET 632/60

CFP/YFP/mCherry
89006 polychroic
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Long term imaging (between 24 and 96 hours) was performed in DMEM with 10% FBS,
and in 5% CO2.

The temperature was maintained at 37oC

using a homemade

temperature box. Cells were imaged in Matek dishes or in 24-well dishes. Imaging in 24
well dishes was done to increase the number of cell conditions per experiment. Dishes
(Mattek or 24 well dishes) were wrapped in parafilm or laboratory tape to minimize the
loss of 5% CO2 Media exchange was performed at least every 24 hours during imaging
was performed using tubes inserted through the top of the dish. The 5% CO2 was also
perfused through the top of the dish. At least three fields per well was accquired over an
experiment. Media exhange occured via tubes inserted through the top of the dishes.
Untreated cells at 92 hours appeared normal.

Confocal microscopy differs from widefield microscopy in that it eliminates out
focus light using a pinhole. Confocal imaging was performed on a Zeiss510 confocal
microscope using a 60x objective. (BioImaging Facility, The Rockefeller University).
Fluorophores were excited using a laser excitation source (Table 5).

Cells were

maintained at 37oC using a Warner Heating Chamber, and were imaged in Cell Imaging
Media (Hanks BBS (Sigma) 9.8g/L, 10mM Hepes; 5% FBS; pH 7.4). Image acquisition
was performed with Zeiss software. The following fluorophores were imaged with the
following filters:

153

Table 6: Confocal Microscopy Filters
Fluorophore

Excitation Filter

Emission Filter

Dichroic

mCerulean

458 laser

473-498 BP

458/514 dichroic

HQ 520/50

488/543 dichroic

GFP
mCitrine

514 laser

550/50 BP

458/514 dichroic

mCherry/TMRE

543 laser

560 LP

488/543 dichroic

We also used total internal reflection microscopy to image single mitochondria
releasing cytochrome c at rapid time resolution. Excitation was with a 488nm (Spectra
Physics) and 561nm (Melles Griot) laser for GFP and mCherry respectively, a 488/561
polychroic mirror, a Cairn OptosplitIII image splitter (Cairn Research) with a 580lp
dichroic to split the channels and emission filter 525/50 for GFP and 632/60 for mCherry,
and an OrcaER CCD camera. The TIR microscope was controlled with Metamorph
software . All filters and dichroics are from Chroma.
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Chapter Two Methods

Plasmid Design
This outlines the cloning details to make the constructs. All primers are listed in
5‟  3‟ format. All primers were ordered from Genelink. The pmDEVD reporter was
anchored to the plasma membrane by using the N-terminal palmitoylation site from GAP43. This was PCR amplified from pECFPmem (Clontech) using the primers:
Forward:

GCGCGCTAGCAATAGATCTTGTTTAGTGAACATGCT
GTGCTGTATGAGA

Reverse:

GATGAGGACCAAAAGATCTCATCGTCTGAATTGTCT
GGTGATGAAGTTGATGGATCTTCTGGTTCTGAATTCG
CGC

The DEVD site is contained in the reverse primer. This was inserted into the
pECFP-C1 vector in the restriction sites NheI and EcoRI. Fluorescent proteins were
swapped by digesting with EcoRI and XhoI, and inserting fluorescent proteins PCR
amplified with the primers:
Forward:

GCGCGAATTCTCATCTACCGGTATGGTGAGCAAGGG
CGAG
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Reverse:

ATGGACGAGCTGTACAAGCTCGAGCATAACTAAGGA
TCCGCGC

This encodes the construct shown in Figure 5:
Palmitoylation- sselsgdevdgssgsefssstg-Fluorophore

The pmControl construct is a variant of pmDEVD without the DEVD. This was
made by PCR amplifying the palmitoylation site with primers that did not contain the
DEVD site:
Forward:

GCGCGCTAGCAATAGATCTTGTTTAGTGAACATGCT
GTGCTGTATGAGA

Reverse:

GATGAGGACCAAAAGATCTCATCGTCTGAATTGTCT
GGTGGATCTTCTGGTTCTGAATTCGCGC

This resulted in the construct:
Palmitoylation-sselsggssgstg-Fluorophore
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pCaspase-3 sensor was initially distributed by Clontech with a GFP, which limits
the simultaneous observation of other fluorophores. We first amplified the NES from the
pCaspase-3 sensor and in the process added a DEVD domain, and an EcoRI site. This
was inserted into the NheI and AgeI sites in pECFP-C1. Next, we amplified mCherry
and inserted this into the AgeI and XhoI sites. Next, the NLS from the pCaspase-3 sensor
was amplified and inserted between the XhoI and BamHI sites. Finally to create a
control plasmid, we inserted amplified mCerulean using the control primers, and inserted
these between the EcoRI and XhoI sites. The primers used are below:

NES Primers:
Forward:

GCGCGCTAGCAATAGATCTTGTTTAGTGAACATGAA
CCTGGTGGACCTC

Reverse:

GAGCTGGACGAGCAGCAGGAATTCTCATCGTCTGAA
TTGTCTGGTGATGAAGTTGATGGATCTTCTGGTTCTT
CATCTACCGGTGCGC

Fluorescent Protein Primer:
Forward:

GCGCACCGGTATGGTGAGCAAGGGCGAG
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Reverse:

ATGGACGAGCTGTACAAGCTCGAGCATAACTAAGGA
TCCGCGC

NLS Primers:
Forward:

GCGCCTCGAGTCTGATCCAAAAAAGAAGAGA

Reverse:

GGATCCACCGGATCTAGATAAGGATCCGCGC

Control Primer
Forward:

GCGCGAATTCTCATCGTCTGAATTGTCTGGTGGATCT
TCTGGTTCT

Reverse:

ATGGACGAGCTGTACAAGCTCGAGCATAACTAAGGA
TCCGCGC
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To create the erDEVD reporter, the first transmembrane domain of Sec63 was
PCR amplified from a cDNA library using the primers:
Forward:

GCGCGCTAGCATGGCCGGGCAGCAGTTC

Reverse:

TGGTATCGTAAGCTTTCTGAA TTCGCGC

This was inserted into the aforementioned pCaspase-3 vector, excising the NES resulting
in:
Sec63(1-68)-sselsgdevdgssgstg-Fluorophore-NLS(3)

The erControl construct was created by inserting the Sec63 (aa 1-68) into the
pCaspase-3 Control reporter using the erDEVD primers, and the restriction sites EcoRI,
and NheI. This resulted in the following construct:
Sec63(1-68)- sselsggssgstg -Fluorophore-NLS(3)

This FRET-DEVD construct was made using the CyPet and yPet vectors which
have been optimized to produce a large change in FRET. This was created by PCR
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amplifying CyPet using the primers below and inserting into the NheI and BamHI
restriction enzyme sites of pEGFP-C1
Forward:

GCGCGCTAGCATGGTGAGCAAGGGAGAG

Reverse:

ATGGACGAACTGTACAAATCCTCGTCCGAGCTCAGC
GGAGATGAGGTCGATGGATCCCCAAA

Subsequently yPet was amplified using the primers below and placed into the
BamHI and HindIII sites in the previous vector.
Forward:

TTTGGGGATCCAGCGGAAGCGAATTCTCTTCAACCG
GTATGGTGAGCAAAGGCGAAGAG

Reverse:

AACGAGCTCTATAAGTAAAAGCTTGCGC

The DEVD site is contained in the primers:
CyPet–sselsgdevdgssgsef-yPet
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Reporter Quantification
Analysis of changes in live single cell fluorescence (for initial reporter
characterization experiments) were quantified in Metamorph. To quantify changes in the
pmDEVD reporter, a single region within the cytoplasm was chosen.

Fluorescent

proteins fused to the palmitoylation domain localize to the Golgi as well as the plasma
membrane.

Therefore in choosing a cytoplasmic region to quantify the changes in

fluorescence, the Golgi aggregate fluorescence was avoided. To quantify fluorescent
changes in the erDEVD reporter and the pCaspase-3 sensor, we monitored nuclear
fluorescence.

Finally changes in the FRET-DEVD construct were quantified by

monitoring the ratio of CFP/YFP in a single cytoplasmic region.

During all

quantification, a background subtraction of each fluorescent channel was performed.

TUNEL Staining
TUNEL staining was performed to assay double stranded breaks. Cells were
transiently transfected with the pmDEVD reporter, treated with staurosporine (2µM),
fixed at different time points, and were stained. TUNEL staining of STS (2µM) treated
HeLa cells was performed in glass bottom 96 well plates (BDBiosciences). We analyzed
untreated cells, thereby determining a fluorescence range for non-apoptotic cells, and we
also monitored cells that were treated for 8 hours with STS, and determined an apoptotic
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range. In each well we determined whether cells were TUNEL positive, and transfected
with the pmDEVD-mCherry reporter. In each well this was continued until we counted
50 transfected cells, and 50 untransfected cells. The percentage of TUNEL positive cells
for transfected and untransfected cells was calculated, and averaged over three wells for
each time point.
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Chapter Three Methods
Plasmids
The G1/S cell cycle reporter consists of the PSLD domain (amino acids 957-1087
of human DNA Helicase B) fused to mCitrine. The reporter is in the nucleus in G1
phase, and translocates to the cytoplasm during the G1/S transition when PSLD is
phosphorylated by CyclinE-CDK2. The PSLD domain from Human DNA Helicase B
was PCRed from a HeLa cDNA library using the primers below. This was inserted into a
vector similar to pEGFP-C1 (between XhoI and EcoRI) with mCitrine in the place of
EGFP.
Forward:

GCGCCTCGAGCTTCTAGCGGCGCACCTCCA

Reverse:

GATAATCAAGAAACTTAGGAATTCGCGC

The triple repeat of the SV40 NLS was PCR amplified from pEYFP-Nuc and
placed into a vector similar to pEGFP-C1 with mCerulean in the place of EGFP between
the restriction sites XhoI and EcoRI.
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Correlation between Inter-Cell distance and Caspase-3/7 activation
The determination of the position of cells and their times of apoptosis was
performed in Metamorph and Excel. The time of caspase-3/7 activation was determined
by circling a region which was approximately the center of cells and determining when
fluorescence irreversibly increased above background. When this did not give a clear
result (potentially owing to movement of the cell) the time of caspase-3/7 activity was
visually determined by looking at the time-lapse images. If the onset of caspase-3/7
activation was still not clear, the cell was excluded from the analysis. The center of the
circled region was recorded as the position of the cell. The position of cells was the
position at the time of drug treatment.
Analysis of the distance between cells and their times of apoptosis was performed
in MatLab. The program would get the position and times of apoptosis of all cells in a
field. Distance was calculated as the distance between the approximate center of cells,
and not the edges of cells. For every cell pairing the distance and the absolute value of
the difference of caspase-3/7 activation in the cells was calculated. This data was binned
based on distance producing plots such as Figure 15. Error bars indicate the 95%
confidence interval of the mean so as to visualize the confidence in the average and not
the distribution.
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For analysis of inter-cell distance and caspase-3/7 activation for cells that were
not sister or cousin cells, we performed the same analysis as above, but excluded sister or
cousin comparisons from the calculation.
Analysis of plating at different times and correlating distance to difference in
caspase activation was performed as above. The times of the actual caspase activation
difference was normalized to the caspase activation difference for cells whose position
were randomly reassigned (null hypothesis). This was a result of variability in the time
difference for cells that are very far apart at the different plating times.

Cell Cycle Analyses
Long term imaging was performed on the Olympus IX-81 in widefield
microscopy. The analysis of the time of onset of caspase-3/7 activation was performed in
Metamorph. The specific time of caspase-3/7 activation, as measured by pmDEVDmCherry, was determined as the time when the cytosolic fluorescence irreversibly
increased above the basal level. Cell tracking and the analysis of the G1/S transition was
performed in Imaris (using the Spot Module). Specifically, the nucleus was tracked using
Cerulean-NLS. For a single cell, this resulted in a moving region of interest marking the
nucleus. The nuclear fluorescence of the mCitrine-PSLD reporter was quantified in this
moving region of interest, and the time course data was exported to Excel. The time of
the G1/S transition was characterized as the time when the mCitrine-PSLD nuclear
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fluorescence irreversibly decreased from the basal G1 levels (see Figure 18 for an
example of the PSLD-mCitrine time course data). After the addition of the drugs the
cells were not as dynamic, therefore the nuclear tracking was not required to measure the
pmDEVD-mCherry reporter.
Alternatively, cell cycles were synchronized with a double thymidine block (15 hr
block, 10 hr release, 15 hr block) and released for variable times (Figure 165). Controls
to determine DNA content was performed with Hoechst staining (Sigma). Briefly, cells
were trypisined, fixed in 4% PFA, and stained with Hoechst (1ug/mL, 20 min), and
analyzed with BD LSRII flow cytometry analyzer (BS BioScience). One way ANOVA
performed in Excel (Fig. S5)

Analysis of Sister Cells and Cell Lineage
Sister cell pairs were visually determined by monitoring division up to 36 hours
before drug treatment. Comparisons of the average time of apoptosis for different cell
types and different stimuli (Figure 28) was calculated in Excel.

The randomized

differences were calculated by taking actual times of apoptosis and randomly pairing
these in Excel.
Cell death of only part of the population (44% of the population) was induced by
using a 1µM STS treatment for 45 minutes. Cells were washed 3 times in fresh DMEM
after treatment.

Within 36 hours of drug treatment there were some cells that did not
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divide or undergo apoptosis. We counted these non-apoptotic, non-dividing cells as
surviving. Chi-squared test was performed with p calculated for 2 degrees of freedom
(Figure 29).
Analysis of the difference in apoptosis between related cells was performed in
MatLab (Figure 31). The time of apoptosis of each cell, and a four number identifier of
the ancestry of each cell was inputted into the program. Cells that shared the same first
number were sister cells, cells that shared the same second number, but not the same first
number were cousin cells, etc. The program would then calculate the difference in the
time of caspase-3/7 activation for each pairing of cells, and store it in 4 different arrays
depending on the relationships between the cell (i.e. if cells were sister cells, data was
stored in array 1, if cells were cousin cells, data was stored in array 2, etc.). Histograms
were plotted in Excel. Data fit for the memory of the cell was performed using the
Marquadt-Levenberg Algorithm in Origin or non-linear least squares fit algorithm in
MatLab using all the data points, and not the average data points. One way ANOVA of
clonal cell lines was performed in Excel (Figure 33).

Intergenerational Differences of Caspase Activation
A subset of sister cells from Figure 34. 4A was re-analyzed to determine both the
time of apoptosis, and the time since division. Cells were fit to recovering exponential
curve as performed in MatLab with calculations for the 95% CI of the fit (Figure 34).
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Cells were grouped into bins of 500 minutes to demonstrate intra-generational trends
using Excel (Figure 34). Error bars of said binned data represent 95% confidence
interval of the mean.

Protein Synthesis Inhibition
Protein synthesis was inhibited using Cycloheximide (C7698), and Puromycin
(Sigma P7255). Treatment regimes are shown in Figure 35 and 37A. S9A,10A. Media
with CHX or puromycin was added through the top of the dish.
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Chapter Four Methods
Plasmids
Plasmids (Cytochrome c-GFP, Mito-mCherry, and Smac-mCherry) were
transfected using Lipofectamine 2000 (Invitrogen). TMRE (Molecular Probes) was added
at a concentration of 25 ng/mL for 15 minutes prior to drug addition. Cytochrome-c GFP
vector was obtained from Douglas Green (Goldstein et al., 2000). Smac-mCherry was
made by inserting mCherry in the place of CFP in the Smac-CFP vector (from Richard
Youle). mCherry was obtained from Roger Tsien, and was placed into a vector similar to
EGFP-C1 (mCherry-C1, made by Florence Koeppel). mCherry was cut using EcoRI and
XhoI restriction enzyme sites and inserted into the corresponding region of Smac-CFP.
Mito-mCherry (a fluorescent fusion of the localization tag of cytochrome c oxidase IV)
was made by inserting mCherry in the place of DsRed in the mito-DsRed vector (Rizzuto
et al., 1995). This was done by inserting mCherry from mCherry-C1 into mitoDsRed
using the sites AgeI and XhoI.
Cells were transfected with cytochrome c-GFP 72 hours before addition of the
apoptotic drug to allow time for proper cytochrome c-GFP localization. In experiments
involving co-expression of Smac-mCherry or mito-mCherry, cells were transfected a
second time 24 hours before the beginning of imaging. An area containing at least 2
transfected cells was imaged at once every 2 minutes until one cell in the field of view
released cytochrome c. Then the rate of imaging was increased to once every 10 seconds.
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Microscopy Controls
Microscopy controls: Cells were imaged under experimental conditions in the
absence of any apoptotic trigger and the release of cytochrome c-GFP from the
mitochondria was never observed indicating that the release of cytochrome c-GFP was
not a consequence of the imaging conditions.
Untreated cells loaded with TMRE were imaged and used to set excitation
intensity and exposure times that did not induce spontaneous mitochondrial
depolarizations from free-radical production (Huser et al., 1998). Cells were imaged
under experimental conditions in the absence of any apoptotic trigger and the release of
cytochrome c-GFP from the mitochondria was never observed indicating that the release
of cytochrome c-GFP was not a consequence of the imaging conditions.

Image and Data Analysis
Data was analyzed with Metamorph. The FRET ratio was calculated as CFP/YFP
after background subtraction. Analysis of the cell cycle reporters were conducted using
Spot Detection in Imaris (Bitplane, Saint Paul, MN). Analysis of the differences in times
of apoptosis relative to both lineage and distance were performed in MatLab and Excel.
Curve fitting was performed in Origin using the Marquardt-Levenberg Algorithm or
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MatLab. Flow cytometry was performed using the BD FACS Aria, and BDLSRII (BD
Biosciences, Flow Cytometry Facility at The Rockefeller University).
Image analysis was performed with Metamorph software (Universal Imaging).
Circular regions of interest (ROIs) with an area of 3μm were selected on the cytochrome
c-GFP image. Many ROIs were selected such that a majority of the mitochondria were
included within at least one ROI. The ROIs were then transferred to the other channel.
The average intensity of each ROI over time was calculated. The time of release for the
ROI was selected by eye as the time when the intensity began to decline irreversibly. If
such a point could not be determined, the ROI was discarded. The x,y location of each
ROI was recorded and the linear distances were calculated from the ROI that had the first
cytochrome c release. (see Figure 40).

Statistical Analysis
All data were analyzed with excel software (Microsoft).

The analysis was

performed using the Student‟s t-test.

BAPTA-AM and Thapsigargin Experiments
Media Changes: BAPTA-AM and Thapsigargin experiments required media
changes during imaging. These experiments were performed in MatTek dishes, and
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media exchange occurred via syringes connected to thin tubing inserted through the top
of the MatTek dish.
BAPTA-AM (1mM) (Alexis) and thapsigargin (5µM) (Sigma) were used to alter
calcium signaling. To reduce extracellular calcium levels, we added EGTA (1.2 mM)
(Sigma) to CIM. We conducted three different experiments. The control experiment was
the addition of TRAIL (1 μg/mL) to cells. In these experiments EGTA and TRAIL were
added to cells in CIM.
The second experiment required the addition of BAPTA-AM (1mM) to quench
cytosolic calcium. BAPTA-AM was not added at the beginning of the experiment.
BAPTA-AM addition was delayed to minimize unintended consequences of the 1mM
concentration. Instead, TRAIL and EGTA were added to cells in CIM, and after the first
cell released cytochrome c BAPTA-AM was added. During the addition all media was
removed from the MatTek dish, and replaced with fresh CIM, TRAIL, EGTA, and
BAPTA-AM. Analysis was conducted on cells that began to release cytochrome c at
least 5 minutes after the addition of BAPTA-AM. Control experiments showed that this
is an appropriate time to ensure cytosolic calcium buffering.
The third experiment involved adding thapsigargin to deplete the endoplasmic
reticulum (ER) calcium.

Previous studies in HeLa cells indicated that Tg takes

approximately 20 minutes to deplete ER calcium (Palmer et al., 2004). Tg and EGTA
were added to the CIM at the beginning of the experiment (prior to the addition of
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TRAIL). After 20 minutes the media was removed and replaced with CIM containing
TRAIL, EGTA, and thapsigargin.
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